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ABSTRACT 
THE NATURAL AND ORTHOGONAL INTERACTION (NOIA) MODELS FOR 
QUANTITATIVE TRAITS (QTs) AND COMPLEX DISEASES 
Publication No.________ 
Feifei Xiao, M.S. 
Supervisory Professor: Christopher I. Amos, Ph.D. 
 
 
      My dissertation focuses on developing methods for gene-gene/environment interactions and 
imprinting effect detections for human complex diseases and quantitative traits.  It includes three 
sections: (1) generalizing the Natural and Orthogonal interaction (NOIA) model for the coding 
technique originally developed for gene-gene (GxG) interaction and also to reduced models; (2) 
developing a novel statistical approach that allows for modeling gene-environment (GxE) 
interactions influencing disease risk, and (3) developing a statistical approach for modeling genetic 
variants displaying parent-of-origin effects (POEs), such as imprinting. 
      In the past decade, genetic researchers have identified a large number of causal variants for 
human genetic diseases and traits by single-locus analysis, and interaction has now become a hot 
topic in the effort to search for the complex network between multiple genes or environmental 
exposures contributing to the outcome. Epistasis, also known as gene-gene interaction is the 
departure from additive genetic effects from several genes to a trait, which means that the same 
alleles of one gene could display different genetic effects under different genetic backgrounds. In this 
study, we propose to implement the NOIA model for association studies along with interaction for 
human complex traits and diseases. We compare the performance of the new statistical models we 
developed and the usual functional model by both simulation study and real data analysis. Both 
simulation and real data analysis revealed higher power of the NOIA GxG interaction model for 
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detecting both main genetic effects and interaction effects. Through application on a melanoma 
dataset, we confirmed the previously identified significant regions for melanoma risk at 15q13.1, 
16q24.3 and 9p21.3. We also identified potential interactions with these significant regions that 
contribute to melanoma risk.   
      Based on the NOIA model, we developed a novel statistical approach that allows us to model 
effects from a genetic factor and binary environmental exposure that are jointly influencing disease 
risk. Both simulation and real data analyses revealed higher power of the NOIA model for detecting 
both main genetic effects and interaction effects for both quantitative and binary traits. We also 
found that estimates of the parameters from logistic regression for binary traits are no longer 
statistically uncorrelated under the alternative model when there is an association. Applying our 
novel approach to a lung cancer dataset, we confirmed four SNPs in 5p15 and 15q25 region to be 
significantly associated with lung cancer risk in Caucasians population: rs2736100, rs402710, 
rs16969968 and rs8034191. We also validated that rs16969968 and rs8034191 in 15q25 region are 
significantly interacting with smoking in Caucasian population. Our approach identified the potential 
interactions of SNP rs2256543 in 6p21 with smoking on contributing to lung cancer risk. 
      Genetic imprinting is the most well-known cause for parent-of-origin effect (POE) whereby a 
gene is differentially expressed depending on the parental origin of the same alleles. Genetic 
imprinting affects several human disorders, including diabetes, breast cancer, alcoholism, and 
obesity. This phenomenon has been shown to be important for normal embryonic development in 
mammals. Traditional association approaches ignore this important genetic phenomenon. In this 
study, we propose a NOIA framework for a single locus association study that estimates both main 
allelic effects and POEs. We develop statistical (Stat-POE) and functional (Func-POE) models, and 
demonstrate conditions for orthogonality of the Stat-POE model. We conducted simulations for both 
quantitative and qualitative traits to evaluate the performance of the statistical and functional models 
with different levels of POEs. Our results showed that the newly proposed Stat-POE model, which 
ensures orthogonality of variance components if Hardy-Weinberg Equilibrium (HWE) or equal 
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minor and major allele frequencies is satisfied, had greater power for detecting the main allelic 
additive effect than a Func-POE model, which codes according to allelic substitutions, for both 
quantitative and qualitative traits. The power for detecting the POE was the same for the Stat-POE 
and Func-POE models under HWE for quantitative traits. 
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CHAPTER 1 
Introduction 
 
1.1 Genetic Association Analyses for Finding Causal Variants for Human Complex Traits and 
Diseases 
        For the past several years, searching for genetic factors that cause various human complex traits 
and diseases has become one of the most important and challenging goals for modern geneticists. 
Genome-wide association studies (GWASs) have contributed substantively to this goal [1-3]. In this 
approach, every locus is isolated and analyzed. Several hundred thousand single nucleotide 
polymorphisms (SNPs) in thousands of individuals are assayed, which has provided a powerful 
approach for investigating the underlying genetic architecture of human complex traits and diseases 
[4, 5]. GWASs have identified a large number of causal variants for human genetic diseases and 
traits, such as cancer, diabetes and heart diseases [6-8], and have provided valuable insights into the 
complexities of the human diseases. For example, about 90 loci have been identified for association 
with the common human trait, height, and have explained about 56% of the overall phenotypic 
variance [9]. GWAS also identified common variants which account for 32% of narrow-sense 
heritability of body mass index [10]. 
      The goal of GWASs is to identify common variants for common diseases, but explaining a large 
and missing proportion of the heritability of most complex or multifactorial diseases and disorders is 
still a challenging task in the field of genetic epidemiology. A limitation of this approach that has 
been cited is that interactions between loci or between genes and environmental exposures are 
usually ignored [11, 12].  For this reason, more efforts are being made to characterize the complex 
network between multiple genes and environmental factors that contribute to disease outcome. 
Potential gene-gene or gene-environmental interactions have been indicated in recent years, but few 
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of them have been validated. The underlying biological pathways could be successfully elucidated as 
more and more interactions are uncovered. Aside from interactions, structural variation, such as copy 
number variations (CNVs), may account for some of the missing heritability if those variants 
contribute to the genetic basis of the human disease [13, 14]. Imprinting effects and rare variants 
may also account for part of the missing heritability too [15, 16]. Rare variants (minor allele 
frequency<0.5%) are not well captured by the GWA genotype arrays because of their small minor 
allele frequency, although they may have substantial effect sizes and contribute in aggregating to the 
burden of disease from genetic factors  [17-19]. 
 
1.2 Usual Functional Models for Genotype-Phenotype Mapping  
        We first briefly review the usual functional models for genotype-phenotype mapping. In the 
usual approach for genotype-phenotype mapping of a quantitative trait locus (QTLs), if the trait is 
influenced by a single diallelic locus, with alleles A and A, we let minor allele be A. Assume we 
have a sample with n individuals. For the i-th individual, let y be the observed trait phenotype and  
G  be the genotypic value for specific locus. We use y to denote the vector of the observed trait 
which is normally distributed and y  y, y, … , y. We model the phenotype as  y 
G  ε. The vector G  Z · G, where G denote the vector of genotypic values including G, G and G as the genotypic values for the three possible genotypes for alleles A and A; the n 
rows of matrix Z represent the corresponding genotype. Therefore, the vector of the observed 
phenotypes G could be expressed as 
"#
$GG%%G &'
( 
"
#$
1% 0% 0%0% 1% 0%0% 0% 1% &
'( · )GGG*.                                                (1) 
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Several methods have been proposed for mapping a quantitative trait controlled by one locus with 
two alleles [20]. The vector of genotypic values G can be modeled as the product of genetic-effect 
design matrix S and the vector of genetic effect E. 
G  S · E.                                                                     (2) 
Let X be the design matrix for the whole sample, X  Z · S. Therefore, we obtain the regression of 
genetic effects as the form y  X · E  ε  Z · S · E  ε  Z · G  ε, where ε is the error term. 
Different mapping methods focus on the core design matrix, S. One of the usual regression models, 
which is referred to as a functional model, can be described as follows [20]: 
G  )GGG*  S.E.  )
1 0 01 1 11 2 0* )
Rad*.                                           (3) 
For an individual with genotype G, the coding will be the first row of the design matrix S., and for 
an individual with genotype G, the coding will be the second row of the design matrix S.  
      The inverse of equation (3) is  
E.  )Rad*  S.G  1
1 0 02  0 2  1 2 3 )
GGG*.                                    (4) 
Here, the reference point R corresponds to the genotypic value of one of the two homozygotes, G. 
The additive effect, a, is half of the difference between the two homozygotes genotypic values. The 
dominance effect, d, is the difference of the heterozygote genotypic value and the average of the 
homozygotes genotypic values. Estimation of the genetic effects, a and d, could be performed by 
linear regression for quantitative trait or logistic regression for qualitative traits. The coding in 
equation (4) is referred to as Func-Usual modeling in our study. Another usual functional model 
codes the additive effect as (-1,0,1) for the three genotypes and the reference point corresponds to the 
average genotypic values of the two homozygotes [20]. These two usual functional models have the 
same estimators except the intercept term, and we therefore will not consider the second model in 
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what follows. These models are called functional models since they use natural effects of allele 
substitutions as parameters, mainly focusing on the biological properties [21].  
 
1.3 The Natural and Orthogonal Interactions (NOIA) model and Its Advantage for Association 
Studies 
      A second approach to modeling, the “statistical model”, referred as the NOIA statistical model, 
was proposed by Alvarez-Castro and Carlborg et al. for estimating genetic effects for a quantitative 
trait and gene-gene (GxG) interactions [21]. As shown in Ma et al. [22], G could be expressed as, in 
the NOIA model, 
G  )GGG*  S4E4  5
1 2N7 22pp/V1 1 2 N7 4pp/V1 2 2 N7 22pp/V; <
μαδ@,                             (5) 
which ensures orthogonality of the estimated parameters. Here, pA denotes the genotype frequencies 
of this locus in the population, where ij  11,12 or 22. N7  p  2p , V  p  4p 2Cp  2pD  p  p 2 Cp 2 pD. N7 is the expected value of N and  V is the variance of N. N is the number of variant alleles (A, for example) which is equal to 0, 1 or 2 when the genotype 
is G, G, or G, respectively. 
      The inverse of equation (5) is 
E4  <μαδ@  S4G  5
p p ppE pE pE2  1 2 ; )
GGG*,                                   (6) 
with 
pAE  pA FGHF7I .                                                           (7) 
        The genetic effects, E4, are based on the genotype frequencies of this locus in the population. 
Alvarez-Castro et al. [23] noted that the statistical model is an orthogonal model that has 
uncorrelated estimates of the parameters, which was also reflected by variance components 
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decomposition [22]. The statistical model (Equation (5)) and the functional model (Equation (3)) can 
be transformed to each other using: 
)Rad*  )
1 N7 p0 1 pE0 0 1 * <
μαδ@.                                                       (8) 
We notice that these two models have the same estimators for the dominant effect and different 
estimators for the additive effect. 
      As pointed out by Alvarez-Castro and Carlborg, there are two main advantages for the 
orthogonal models [21]. First, it makes model selection straightforward as the estimates are 
consistent in reduced models. Second, it enables accurate variance component analysis because of 
independent estimation of the genetic effects. A model with design matrix X satisfying X · X being a 
diagonal matrix will be an orthogonal model [21]. That is 
X · X  JS · ZK · Z · S  nS · Q · S, 
where  
Q  )p 0 00 p 00 0 p*. 
And given that S  JsAK with s  1, the criteria for orthogonality of the genetic regression model 
was derived by Cockerham and denoted in terms of our notation as following [21]. To attain 
orthogonality, one sets the off diagonal elements of the X · X matrix to be zero since it will then 
follow that S · Q · S is a diagonal matrix. 
sp  sp  sNp  0, sNp  sNp  sNNp  0, ssNp  ssNp  sNsNNp  0. 
       The statistical model fulfills these criteria and shows orthogonality for detecting and estimating 
genetic effects, whereas some parameters of the functional model (Equation (3)) are confunded, 
which can cause issues in hypothesis testing when Wald-type tests are used (as we shall see later in 
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the dissertation). The statistical model uses average effects of allele substitutions in populations as 
parameters for the decompostion of genetic variance. Its statistical formulation provides an approach 
in which the estimates of the genetic effects remain orthogonal; that is, they are consistent in reduced 
and unconfouned in the full model. This holds true even if Hardy-Weinberg Equilibrium (HWE) is 
violated. The orthogonality of the NOIA model is attractive becuase it ensures that the estimated 
genetic effects are not statistically correlated, rendering a more meaningful calculation of heritability 
of a trait comparing to the traditional models. The orthogonality of the statistical formulation of 
NOIA framework become important when multiple loci are contributing to the outcome. This is also 
why we were motivated to do the following studies.  
 
1.4 Testing Statistics of the Usual Functional Model and NOIA Statistical Model 
      To further understand the statistical characteristic of the usual functional model and the NOIA 
statistical model on testing the additive effect with or without dominant effect detection, we 
constructed the Wald test statistics for these two models before and after the dominance component 
is removed (details see Appendix 2.2). The Wald test statistic is z  PQRSJPQK  JTUTKVWTUXRSJPQK  where βZ 
denotes the vector of the estimation of the genetic effects and varJβZK  σCXEXD. 
      We constructed the test statistic of the functional model with both additive and dominance effect 
detection as following.  XEX  n 5 1 N7 pN7 p  4p pp p p; which is not a diagonal matrix. The test 
statistic for the functional model is  
√_`I
"
###
$ a IbWW 0 02a b``IbWWCbW`D 0 a bWWIb``CbW`D2abW`b``bWW 2abWWb``bW` 2abWWbW`b`` &
'''
( ZEy,  
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with the linear combination of the second or third row and  ZEy for the additive effect testing or 
dominant effect testing, respectively. We also constructed the test statistic of the functional model 
with only additive effect detection as follows. XEX  n c1 N7N7 N7  2pd . The test statistic for the 
additive functional model is 
√_`I )eN7  2p b``eF7fb`` bW`eF7fb``2N7 1 2 N7 2 2 N7 * ZEy, 
with the linear combination of the second row and  ZEy for the additive effect testing.  
      In what follows, we show the Wald test statistic of the NOIA model with both additive and 
dominance effect detection. XEX  n 51 0 00 V 00 0 
bWWbW`b``I ; which fulfills the requirement of the 
orthogonality that we discussed in Section 1.3. The test statistic for the NOIA statistical model is 
√_`I  "$
√V √V √V2N7 1 2 N7 2 2 N72abW`b``bWW 2abWWb``bW` 2abWWbW`b`` &( Z
Ey, 
with the linear combination of the second or third row and  ZEy for the additive effect testing or 
dominant effect testing, respectively. After we remove the dominance component from the NOIA 
model, XEX  n g1 00 Vh. Moreover, the test statistic for the additive NOIA statistical model after the 
dominance component is removed: 
√_`I c√V √V √V2N7 1 2 N7 2 2 N7d  ZEy, 
with the linear combination of the second row and  ZEy for the additive effect testing.  
      From above formulations, we can clearly state that the NOIA model has same test statistic with 
the usual functional model for additive effect detection when only additive effect testing is included. 
The NOIA statistical model also has same test statistic with the usual functional model for 
dominance effect detection. Obviously, the NOIA statistical model has consistent testing for additive 
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effect detection after the dominance component is added to the modeling, whereas the usual 
functional model loses power. 
 
1.5 Gene-Gene Interactions and Gene-Environment Interactions Contributing to Human 
Complex Traits and Diseases 
      Unlike Mendelian diseases or traits in which single variants influence the outcome, multiple 
factors including genetic and environmental factors contribute to the complex diseases/traits. As 
stated in section 1.1, the interactions among different loci and environmental exposure are usually 
ignored in the usual GWAS. Accurate modeling of associations along with interactions remains a 
challeging task for geneticists. The term gene-gene (GxG) interaction, also called epistasis, has 
various definitions. The most common statistical definition of epistasis is a departure from additivity 
of genetic effects at each locus from two or more genes that influence a trait; thus, the same alleles of 
one gene could display different genetic effects in different genetic backgrounds. Epistasis has 
become a hot topic for genetic researchers in recent years. It was initially characterized in animal 
model in the early 1900’s as playing an important role in determining some phenotypes. For 
common human diseases and disorders, such as anemia, cystic fibrosis and complex autoimmune 
diseases, the relevance of gene-gene interactions is still under exploration but became a more 
prominent explanation for the failure of GWAS to explain much of the variation in risk among 
individuals in the last decade [24-26]. Moreover, epistasis was recently revealed to be the main force 
in long-term molecular evolution [27]. To test for statistical interactions influencing quantitative 
traits, linear regression may be used including both main genetic effects and interaction effects. For 
binary outcomes, the usual approach for modeling uses a log odds scale that is fitted with logistic 
regression. Several methods have been developed for searching for the interactions when performing 
genetic association studies [28-32]. The major motivation of developing these approaches is to 
improve the power of detecting effects and to provide a more comprehensive assessment of genetic 
architecture influencing a trait [33]. The contribution of enviromental factors in determining human 
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complex diseases has been the provenance of epidemiologists. The role of gene-environment 
interactions in disease etioogy has engaged both geneticists and epidemiologists and there was a 
resurrection of interest in this area starting about a decade ago as geneticists tools became easier to 
use for large scale studies [34]. The interactions between the enviromental exposure and the genetic 
factor, which is called gene-environment (GxE) interactions, are believed to be able to play an 
important role in the genetic archtecture of most human complex traits and diseases. The definition 
of GxE interactions is similar to the GxG interactions. The same alleles of one gene could display 
different genetic effects in different environmental backgrounds. For example, the interaction 
between genetic factors and cigarete smoking exposure contributing to the lung cancer is among the 
most well-know examples of GxE interactions [35]. Individuals with variants of a specific gene may 
be more susceptible to lung cancer risk in smokers; individuals with the same variants may not be 
inclined to increased risk of lung cancer in non-smokers. Therefore, understanding the underlying 
mechanisms may give valuable insights on cancer prevention and possibly treatment. GxE 
interactions have been recently revealed to be play crucial roles on development of Parkinson’s 
diseases, rheumatoid arthritis and lung cancer [36-38].  In recent years, for understanding the 
complexity of genotype-phenotype relationships along with the gene-environment interactions, 
several approaches and software have been developed [39-41]. Unwinding this complexity will help 
in explaining more of the heritability of human complex traits and diseases. 
 
1.6 Imprinting Effect is Usually Ignored in Traditional Association Studies 
      Genetic imprinting frequently affects genes during embryogenesis and is the most well-known 
parent-of-origin effect (POE). Imprinting causes the differential expression of genes based on the 
parental origin of the chromosome [42].The same alleles transmitted from the father have different 
levels of transcription and thus may render a different effect on the phenotype compared with the 
alleles transmitted from the mother. Genetic imprinting has been shown to be important for normal 
embryonic development in mammals [43]. So far, approximately 200 imprinted genes have been 
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validated or predicted in humans (http://www.geneimprint.com). Imprinted genes have been 
implicated in several complex human disorders, including diabetes, breast cancer, alcoholism, and 
obesity [44-47]. Kong et al. identified several variants of known imprinted genes showing significant 
effects on the development of breast cancer, carcinoma and type II diabetes [48]. An allele on an 
imprinted region of chromosome 14q32 was recently identified to affect type I diabetes susceptibility 
by Wallace et al. [49]. 
      Several statistical approaches have been developed for modeling POEs and imprinting effects. 
Shete et al. implemented a variance-components (VC) method for testing genetic linkage by 
incorporating an imprinting parameter [50]. They applied this framework to rheumatoid arthritis and 
gene expression data and found significant signals for linkage [51]. Gorlova et al. developed a QTL 
analysis test to evaluate both total and parent-specific linkage signals based on identity-by-descent 
sharing [16] . Ainsworth et al. also described an implementation of a family-based multinomial 
modeling methodology in which POE detection is considered using mothers and their offspring [52]. 
However, none of above approaches considered the orthogonality properties in the modeling of the 
genetic effects. 
      Most traditional association approaches assume that the two alleles from the parents contribute 
equally to the trait, thereby ignoring the important genetic phenomenon, POEs. These approaches 
estimate the main allelic effect, which could also be considered as the overall genetic effect, without 
considering POEs. As mentioned in Section 1.1, genetic imprinting affects expression of genes and 
may explain some of the missing heritability of human complex traits and diseases. It is important to 
develop new methods applicable to genome-wide scans that model the differential contribution of 
paternal and maternal alleles. It is desired that a method that allows for POE also maintain the power 
to detect the main allelic effect after adding one or more parameters related to POE to the model. 
Therefore, the proper and orthogonal decomposition of genetic variance renders the NOIA 
framework meaningful and useful to estimate main allelic effects along with the POE.  
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      In conclusion, considering the advantages of the orthogonal NOIA model on detecting genetic 
effects, missing heritability and ignored GxG/GxE or imprinting effects by usual association 
approach, we propose to apply the NOIA orthogonal models to characterize the complex network 
between multiple genes, environmental factors and imprinting effect, for investigating the underlying 
architecture of human complex traits and diseases. 
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CHAPTER 2 
Natural and Orthogonal Interaction Framework for Modeling Gene-Gene 
Interactions Applied to Cutaneous Melanoma 
       
      In this chapter, to evaluate the performance of the NOIA statistical model on detecting gene-gene 
interactions that was proposed by Alvarez-Castro and Carlborg [21], we applied the NOIA statistical 
model on both simulated and real data. For testing the gene-gene interactions in the association 
modeling, we added the interaction effect parameters into the modeling which always resulted in lost 
power to detect the main genetic effects, that is, the main additive and dominance effects. The usual 
functional one-locus model (equation (3)) uses natural substitution for the parameter estimations 
which renders a non-orthogonal model whenever a dominance component is modeled, which means 
that the hypothesis tests lose power when the interaction terms are incorporated into the modeling. 
However, the NOIA statistical model (equation (5)) overcomes this disadvantage because of its 
orthogonality [6]. That is, even when we add several additional parameters into NOIA modeling, the 
estimation of the original parameters will not be influenced. Therefore, we propose to formalize the 
NOIA statistical one-locus model in equation (5) to a two-locus model incorporating the detection of 
interactions. We also extended the usual functional one-locus model to compare the performance of 
this testing with the NOIA model. We evaluate the behavior of the NOIA statistical model over the 
usual functional model for detecting the genetic effects, through both simulation analyses and 
application on melanoma dataset. 
        With extensive simulation studies for both quantitative traits and case-control traits, we 
evaluated the performance of NOIA statistical model and usual functional model for detecting the 
main genetic effects and interaction effects. To evaluate the influence of the parameter setting on the 
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simulation results, we simulated different scenarios with positive, negative or zero values of the 
interaction terms. We also extended the NOIA statistical model to reduced models including the 
additive, dominant and recessive models. We evaluated the power and type I error for detecting the 
genetic effects. To further characterize the performance of the two models, we applied them to the 
melanoma dataset to search for casual variants and potential interaction effects influencing 
melanoma risk.  
      GWAS and family-based approaches have previously revealed several loci that influence CM 
risk. Several previous studies have shown that melanocortin 1 receptor (MC1R) located at 16q24.3, 
HERC2/ (HECT and RLD domain containing E3 ubiquitin protein ligase 2)/OCA2 at region 15q13.1 
and cyclin-dependent kinase inhibitor 2A (CDKN2A or p16) at 9p21.3 are the most significant 
susceptibility genes for melanoma susceptibility [53, 54]. Although one-locus association studies 
have been applied widely to investigate melanoma risk widely, the gene-gene interactions underlying 
this disease have not been fully exploited. Understanding how these genetic loci and interactions 
influence the development of melanoma could provide important clues in the pathogenesis and 
treatment of melanoma. 
      In the following sections, we introduce the methodology development of the NOIA and usual 
functional two-locus interaction models and the design of the simulations studies. We describe the 
application of the newly developed methods on a genome-wide scale melanoma dataset. 
 
2.1 Methods 
2.1.1 Two-Locus Gene-Gene Interaction Models 
      We already described the one-locus NOIA statistical model in Section 1.3. To extend the model 
to a two-locus model allowing gene-gene interaction testing, we assumed that a quantitative trait is 
influenced by two diallelic loci, A and B. We use pA and qA to denote the genotype frequencies of 
genotype AA and BA, respectively. Nk is the number of reference allele A, which is equal to 0, 1 or 2 
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when the genotype is G, G or G, respectively. Similarly, Nm is the number of reference allele B. N7k and N7m denote the means of Nkand Nm, respectively, whereas Vkand  Vm denote the variance 
of Nkand Nm, respectively. Therefore, N7k  p  2p, Vk  p  4p 2 Cp  2pD. 
Correspondingly, N7m  q  2q, Vm  q  4q 2 Cq  2qD. 
        For two-locus gene-gene interaction models, which were described by Alvarez-Castro and 
Carlborg [21], the vector of two-locus genotypic values, Gkm, can be built as follows: Gkm  Skm · Ekm  CSmnSkD · Ekm,                                             (9) 
if we assume that the two loci, A and B, and in linkage equilibrium. Ekm is the two-locus vector of 
genetic effects; Skm is the two-locus genetic effect design matrix which is the Kronecker product of 
the design matrix of loci B and A. From NOIA one-locus statistical model (equation (5)), the two-
locus modeling vectors Gkm, Ekm and design matrix Skm can all be obtained by the Kronecker 
product of one-locus modeling as follows:  
Gkm  5GmWWGmW`Gm``; n 5
GkWWGkW`Gk``; 
"
###
###
#$
GmWW · GkWWGmWW · GkW`GmWW · Gk``GmW` · GkWWGmW` · GkW`GmW` · Gk``Gm`` · GkWWGm`` · GkW`Gm`` · Gk``&
'''
'''
'(

"
##
##
#$
GGGGGGGGG&
''
''
'(
,                              (10) 
Skm4  Sm4nSk4 
"#
$1 2N7m 2 oW`o``Ip1 1 2 N7m 
oWWo``Ip1 2 2 N7m 2 oWWoW`Ip &
'( n "#
$1 2N7k 2 bW`b``Iq1 1 2 N7k 
bWWb``Iq1 2 2 N7k 2 bWWbW`Iq &
'(,        (11) 
Ekm4  Em4nEk4  ) 1αkδk* n )
1αmδm* 
"
###
##$
μαkδkαmααδαδmαδδδ&
'''
''(
.                           (12) 
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Therefore, the vector of genotypic values, Gkm, can be expressed as 
"
##
##
#$
GGGGGGGGG&
''
''
'( 
"#
$1 2N7m 2 oW`o``Ip1 1 2 N7m 
oWWo``Ip1 2 2 N7m 2 oWWoW`Ip &
'( n "#
$1 2N7k 2 bW`b``Iq1 1 2 N7k 
bWWb``Iq1 2 2 N7k 2 bWWbW`Iq &
'(
"
###
##$
μαkδkαmααδαδmαδδδ&
'''
''(
.            (13) 
        Through this derivation, we obtain the coding matrix, Skm4, for two-locus association along 
with gene-gene interactions modeling testing by linear regression. For this model, there are nine 
parameters to be inferred, including one baseline term (μ), two additive terms (αkand αm), two 
dominant terms (δk and δm), and four interaction terms (αα, δα, αδ and δδ). This was a full model 
including both additive effects and dominant effects. Reduced models, including additive, dominant, 
and recessive models, were also extended (Appendix 2.1).   
        As described in Section 1.2, the one-locus genotypes are usually coded as (-1, 0, 1) or (0, 1, 2) 
for the additive effect in the usual approach. Dominance effect is sometimes added for full modeling. 
Both of these two models are called a functional model, as it reflects the functionality of the alleles at 
the locus. Unlike the statistical model, the genetic effects from this functional model are using 
natural substitutions rather than based on the population effects which depend upon genotype 
frequencies. Similarly, using the (0, 1, 2) coding approach in equation (3), the two-locus genetic 
effect design matrix can be obtained as the Kronecker product of the two design matrices, 
Skm.  Sm.nSk.  )1 0 01 1 11 2 0* n )
1 0 01 1 11 2 0* 
"
###
##$
1 0 01 1 11 2 0
0 0 00 0 00 0 0
0 0 00 0 00 0 01 0 01 1 11 2 0
1 0 01 1 11 2 0
1 0 01 1 11 2 01 0 01 1 11 2 0
2 0 02 2 22 4 0
0 0 00 0 00 0 0&
'''
''(
.   (14) 
      Therefore, the genotypic values could be expressed as 
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Herein we use Greek letters for the genetic effects to distinguish with those from the statistical 
model. Reduced models, including additive, dominant, and recessive models, were also extended for 
the usual functional model (Appendix 2.1). As in the one-locus functional model, the estimation of 
the parameters was not based on the genotype frequencies and therefore reflects the main and 
interaction effects in a different way compared with the NOIA model. This model is also not 
orthogonal. The relationship between the NOIA statistical model and usual functional model can be 
derived through Skm.Ekm.  Skm4Ekm4 [21] as follows: 
"
###
##$
Rakdkamaadadmaddd&
'''
''(  gSkm. · Skm4h ·
"
###
##$
μαkδkαmααδαδmαδδδ&
'''
''(
.                                        (16) 
2.1.2 Simulation Studies on Quantitative Traits and Qualitative Traits 
        We performed simulation analyses for both quantitative and case-control traits by applying the 
NOIA statistical GxG interaction model and the usual functional GxG interaction model. 
        To simulate samples of independent individuals with a quantitative trait controlled by two 
diallelic loci, we assumed that there was no linkage disequilibrium among the two markers. For locus 
A, a value of the minor allelic frequency (p) was given in the simulated population. Genotypes A, A and A were assigned to an individual with probabilities C1 2 pD, 2pC1 2 pDand p 
respectively. Similarly, the minor allelic frequency (p) was given to locus B. Genotype B, B and 
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B were assigned to an individual with probabilities C1 2 qD, 2qC1 2 qD and q respectively. From 
a prespecified vector of parameters, Ers.  R, ak, dk , ak, dk, aa, ad, da, dd, we assigned each 
individual a genotypic value according to his/her assigned two-locus genotypes. Then, by randomly 
generating a value from a normal distribution with prespecified mean and variance (0 and σS ), we 
generated an observed phenotype/trait by adding this residual to the previously assigned genotypic. 
We used data from 2000 individuals as a replicate and simulated 1000 replicates for each genetic 
model. 
        In this part of our investigation of quantitative traits, three scenarios were simulated with 
different interaction terms (Table 2.1). The minor allele frequencies for both SNPs were set to 0.3, 
and the residual variance σS was 144.0. The true values of the nine parameters in these three 
scenarios are shown in Table 2.1.  
      To investigate whether the setting of allele frequency influences the testing of the effects, we also 
simulated another scenario for quantitative traits. The minor allele frequency was set to be 0.49. The 
pre-specified value for the other terms remained the same. 
      Ma et al. [22] thoroughly derived the formulation of the statistical model in quantitative traits and 
demonstrated that a similar statistical model could also be defined for a qualitative trait by handling 
the genetic effects as the logit scale of the outcome. Similarly, we performed a case-control 
simulation analysis in our study. We used logistic regression and Bayes theorem to set the genotypic 
values of each individual according to the prespecified genetic effect terms, Ers.. For each replicate, 
1000 cases and 1000 controls were simulated, and a total of 1000 replicates were simulated. The 
minor allele frequency was set to 0.30. Three scenarios were simulated with different generating 
values for the interaction terms. The generated values of the parameters in the three different 
scenarios are shown in Table 2.1. 
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Table 2.1 Simulation parameter values of genetic effects for quantitative and case-control traits 
dataset. R is the intercept term; ak and dk are the additive and dominant effects of locus A; am and dm are the additive and dominant effects of locus B; aa, ad, da and dd are the interaction effects 
between locus A and locus B. Interaction coefficients are positive values for scenario 1, negative for 
scenario 2, and zero for scenario 3 which means no interaction. Main additive effect and dominant 
effect all exists in every scenario for both traits.  
 
 t uv wv ux wx uu uw wu ww 
Quantitative trait 
Scenario 1 100.00 1.50 0.40 1.10 0.50 0.80 0.23 0.32 0.12 
Scenario 2 100.00 1.50 0.40 1.10 0.50 -0.80 -0.23 -0.32 -0.12 
Scenario 3 100.0 1.50 0.40 1.10 0.50 0 0 0 0 
Case-control trait 
Scenario 1 -2.0 0.50 0.30 0.40 0.37 0.15 0.08 0.10 0.04 
Scenario 2 -2.0 0.50 0.30 0.40 0.37 -0.15 -0.08 -0.10 -0.04 
Scenario 3 -2.0 0.50 0.30 0.40 0.37 0 0 0 0 
 
2.1.3 Application on Melanoma Susceptibility 
        We applied the NOIA statistical model and the usual functional model to the Cutaneous 
Melanoma (CM) data, samples from a genome-wide case-control study including 1804 cases and 
1026 controls. The SNPs were genotyped from Illumina Omni 1-Quad_v1-0_B array and 783,945 
SNPs remained after the quality control and other filtering procedures were applied [8]. The CM 
samples were collected from patients treated at The University of Texas MD Anderson Cancer 
Center between 1998 and 2008, and the controls were collected from the friends of the patients with 
matched sex and age during the same period. All the participants were non-Hispanic whites. The 
details of the genome-wide case-control study have been described previously [8]. The initial goal of 
that study was to detect novel loci that predisposed whites to CM. The objective of the current study 
was to apply the newly developed methods to validate the already identified potential causal SNPs 
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and gene-gene interactions that contribute to melanoma risk. We also attempted to compare the 
performance of the NOIA statistical model with that of the usual functional model on genetic effects 
detection. Logistic regression was used for the genetic effects estimation, and the P values were 
obtained using the Wald test statistic with the null hypothesis that the coefficient was zero. The 
Manhattan plots for the P values tested for the additive, dominant and interaction effects were 
graphed by Haploview software. 
 
2.2 Results 
2.2.1 Simulation Studies on Quantitative Traits and Qualitative Traits 
        We performed the simulation analysis on both simulated quantitative traits and case-control 
datasets. For each trait, analyses of three scenarios were performed when there were positive, 
negative or zero values for the interaction coefficients (Table 2.1). In each case, the minor allele 
frequency of locus A and locus B was both 0.30, and the residual variance was 144.0 for the 
quantitative trait. 
        First, we performed simulation studies on a quantitative trait under three scenarios. Our first 
simulation exhibited both main effects of two genes and their interactions with the true effect values 
Ers.  R, ak, dk , am, dm, aa, ad, da, dd   100.00, 1.50, 0.40, 1.10, 0.50, 0.80, 0.50, 0.32, 0.12 . 
Figure 2.1 illustrates the power of the NOIA statistical model and usual functional model on 
detecting the four main genetic effects including the additive effects and the dominant effects of 
locus A and locus B, and four interaction effects between locus A and locus B. For detecting the main 
genetic effects, the NOIA statistical model clearly had greater power than the usual functional 
model, especially for additive effects (Fig. 2.1, upper panel). The NOIA statistical model also 
exhibited slightly greater or equal power than the usual functional model for detecting the interaction 
effects except the dominance by dominance effect (Fig. 2.1, bottom panel). The density distributions 
of the parameters estimated from these replicates was shown in Figure S2.1. Clearly, the variance of 
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all the main genetic effects (ak, dk , am and dm) and most of the interaction effects (aa, ad and da) 
estimated from the NOIA statistical model was much smaller than those from the usual functional 
model (Fig. S2.1). Furthermore, the estimations of the genetic effects were both accurate for the two 
models, as the peaks were all located around the simulated true values (Fig. S2. 1). 
 
Figure 2.1 Power under different critical values of the P values obtained using the Wald test for the 
quantitative simulation dataset under scenario 1 when the interaction terms were positive.  The upper 
panel is for the additive effects and dominant effects of locus A and locus B, respectively. The 
bottom panel is for the interaction effect between locus A and locus B. The simulating values of the 
genetic effects were Ers.   100.00, 1.50, 0.40, 1.10, 0.50, 0.80, 0.50, 0.32, 0.12. Corresponding values of the statistical 
genetic effects were Ers4  102.39, 2.35, 0.59, 1.97, 0.74,1.04, 0.28, 0.37, 0.12 . 
 
         To explore whether the values of the interaction terms influence the estimations of the 
parameters, we analyzed another scenario in which the interaction effect coefficients were set to be 
negative values and Ers.  100.00, 1.50, 0.40, 1.10, 0.50, 20.80, 20.23, 20.32, 20.12. A similar 
pattern with the first scenario was detected for the power of detecting the genetic effects; however, in 
this scenario the preference of the statistical NOIA model over the usual functional model in 
detecting the main effect of locus A and locus B was not obvious (Fig. 2.2). For some of the 
parameters, the usual functional model even showed slightly greater power than the NOIA statistical 
model.  
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Figure 2.2 Power under different critical values of the P values obtained using the Wald test for the 
quantitative simulation dataset under scenario 2 when the interaction coefficients were negative. The 
upper panel is for the additive effects and dominant effects of locus A and locus B, respectively. The 
bottom panel is for the interaction effect between locus A and locus B. The simulating values of the 
genetic effects were Ers.  100.00, 1.50, 0.40, 1.10, 0.50, 20.80, 20.23, 20.32, 20.12. Corresponding values of the 
statistical genetic effects were Ers4  101.49, 0.97, 0.21, 0.63, 0.26, 21.04, 20.28, 20.37, 20.12.  
 
      We also analyzed a third scenario, in which there were no epistastic effects and only the main 
genetic effects from the two loci influence the trait (Fig. 2.3). In this scenario, the NOIA statistical 
model still had greater power for detecting the main genetic effects (Fig. 2.3, upper panel). The 
NOIA statistical and usual functional model yielded similar false positive rates for detecting the 
interaction effects, both of which were close to the nominal value (Fig. 2.3, bottom panel). The 
density distributions of the parameters estimated from these replicates in scenario 2 and scenario 3 of 
quantitative traits simulations are shown in Figure S2.2-S2.3. 
 
 
 
 
 
 
  
22 
 
 
 
Figure 2.3 Power under different critical values of the P values obtained using the Wald test for the 
quantitative simulation dataset under scenario 3 when no interaction effects present. The upper panel 
is for the additive effects and dominant effects of locus A and locus B, respectively. The bottom 
panel is for the interaction effect between locus A and locus B. The simulating values of the genetic 
effects were  Ers.  100.00, 1.50, 0.40, 1.10, 0.50, 0.0, 0.0, 0.0, 0.0. Corresponding values of the statistical 
genetic effects were  Ers4  101.94, 1.66, 0.40, 1.30, 0.50, 0.0, 0.0, 0.0, 0.0. 
 
        Figures 2.4-2.6 show the results obtained from the case-control trait simulations. In Figure 2.4, 
the simulating values of the genetic effects were 
Ers.  22.00, 0.50, 0.30, 0.40, 0.37, 0.15, 0.08, 0.10, 0.04, in which main genetic effects and 
interaction effects influence the outcome trait and the interaction coefficients were positive values.  
Similar to the simulation studies of the quantitative traits, the NOIA statistical model had greater 
power than the usual functional model for detecting most of the genetic effect terms. The parameter 
of the dominant-dominant interaction effect was exactly the same between these two models, which 
is expected from the equation of the models (equation (16)). We can see dd  δδ after computation 
of the equation (16) which means that the parameters are identical. The test statistic for these two 
parameters should be identical too which can be implied from the test statistic of the dominance 
effect detection shown in Section 1.3. Interestingly, when we set the interaction terms to be negative 
values, where Ers.  22.00, 0.50, 0.30, 0.40, 0.37, 20.15, 2 0.08, 20.10, 20.04, the power of 
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both models for detecting additive effects of locus A or locus B were similar to the power of these 
two models when the interaction terms were positive (Fig. 2.5).  
        For the third scenario, in which no interaction effects were present for the case-control trait, the 
power of the NOIA statistical model was still greater than that of the usual functional model to detect 
the main effects, while the false positive rates for detecting the interaction effects remained the same 
(Fig. 2.6). For all the scenarios we simulated, the density distributions of the eight parameters are 
presented in Figure S2.4-2.6. The estimation of the genetic effects was accurate, and the variance of 
the effects from the NOIA statistical modeling was less than that from the usual functional model for 
most parameters.  
      In the above analyses, we simulated the minor allele frequency of the two loci to be 0.3. We also 
studied setting the minor allele frequency to be 0.5 (Fig. S2.7-9). In most scenarios we simulated, the 
NOIA statistical model still had greater power than the usual functional model for detecting the main 
genetic effects and slightly greater power in detecting the interaction effects except for the scenarios 
when the interaction coefficients were negative values (Fig. S2.9). To evaluate the false positive 
rates of the two models, we also simulated a null scenario where no any effect existed. The false 
positive rates of the NOIA statistical model in the 0.05 significance level for detecting the eight 
genetic effects are: 0.051, 0.044, 0.054, 0.044, 0.048, 0.061, 0.055 and 0.058. The false positive rates 
of the usual functional model for detecting the eight genetic effects are: 0.042, 0.04, 0.04, 0.037, 
0.051, 0.058, 0.052 and 0.058. 
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Figure 2.4 Power under different critical values of the P values obtained using the Wald test for the 
case-control simulation dataset under scenario 1 when positive interaction effects present. The upper 
panel is for the additive effects and dominant effects of locus A and locus B, respectively. The 
bottom panel is for the interaction effect between locus A and locus B. The simulating values of the 
genetic effects were  Ers.  22.00, 0.50, 0.30, 0.40, 0.37, 0.15, 0.08, 0.10, 0.04. Corresponding values of the statistical 
genetic effects were  Ers4  21.07, 0.78, 0.36, 0.70, 0.45, 0.23, 0.10, 0.12, 0.04 . 
 
 
Figure 2.5 Power under different critical values of the P values obtained using the Wald test for the 
case-control simulation dataset under scenario 1 when negative interaction effects present. The upper 
panel is for the additive effects and dominant effects of locus A and locus B, respectively. The 
bottom panel is for the interaction effect between locus A and locus B. The simulating values of the 
genetic effects were  Ers.  22.00, 0.50, 0.30, 0.40, 0.37, 20.15, 2 0.08, 20.10, 20.04. Corresponding values of the 
statistical genetic effects were  Ers4  21.29, 0.46, 0.24, 0.39, 0.29, 20.23, 20.10, 20.12, 20.04 . 
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Figure 2.6 Power under different critical values of the P values obtained using the Wald test for the 
case-control simulation dataset under scenario 1 when negative interaction effects present. The upper 
panel is for the additive effects and dominant effects of locus A and locus B, respectively. The 
bottom panel is for the interaction effect between locus A and locus B. The simulating values of the 
genetic effects were  Ers.  22.0, 0.5, 0.3, 0.4, 0.37, 0.0, 0.0, 0.0, 0.0. Corresponding values of the statistical genetic 
effects were  Ers4  21.18, 0.62, 0.30, 0.55, 0.37, 0.0, 0.0, 0.0, 0.0.  
 
2.2.2 Application on a Real Dataset: Melanoma Susceptibility 
        To evaluate the performance of the NOIA statistical model and usual functional model, we 
carried out GWAS in the 2831 white participants, including 1805 cases and 1026 controls. To 
identify novel and verify the previously identified potential causal SNPs, we performed initial 
analyses using the one-locus NOIA statistical additive model. The Q-Q plot for the sample is shown 
in Figure S2.10. No obvious inflation of the test (γ  1.011) was observed for the test statistic. Same 
estimations for the genetic effects were found for the one-locus usual functional additive model as 
expected (Section 1.4). Next, we applied the one-locus NOIA model with dominance component 
included to the melanoma dataset. SNPs with very few frequency of rare homozygotes (genotype cut 
off value was 0.005) were filtered and the Q-Q plot is shown in Figure S2.11 (γ  1.014).The one-
locus association results showed that 9 SNPs were significant at the genome-wide association level 
(5.0  10) and 140 SNPs were significant at the 1.0  10
 significance level (Table 2.2 and 
Table S2.1). Of the most significant SNPs that contribute to melanoma risk, two regions were found 
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to be genome-wide significant (Table 2.2). They are located on 15q13.1 (centered at the 
HERC2/OCA2 region and 16q24.3 MC1R region). These two most significant SNPs located in these 
two regions are rs1129038 (P  3.73  10, odds ratio [OR] = 0.70, 95% confidence interval [CI] 
=0.61-0.79) and rs4785751 (P  1.13  10, OR=1.43, 95% CI=1.29 -1.60), respectively. The 
risk variants of these two SNPs were A and G, respectively. The SNPs located around MTAP were 
shown to be the third highly significant regions which are located at 9p21.3. The most significant 
SNP, SNP9-21789598 (P  4.15  10), is located at the 5’-UTR of the MTAP gene, close to the 
CDKN2A gene.  
Table 2.2 Top SNPs result from genome-wide association analysis of melanoma by NOIA statistical 
one-locus model using logistic regression (p  1.0  10). The odds ratio (OR), confidence 
interval (CI) and P value are shown for the additive effect testing. 
 
CHR SNP A1 A2 A2 freq Position OR(95%CI) P value Gene Symbol 
16 rs4785751 A G 0.53 88556918 1.43(1.29-1.60) 1.13E-10 DEF8 
16 rs4408545 A G 0.54 88571529 1.43(1.28-1.59) 3.81E-10 AFG3L1 
16 rs11076650 A G 0.46 88595442 1.40(1.26-1.56) 1.65E-09 DBNDD1 
16 rs8051733 A G 0.36 88551707 1.42(1.27-1.59) 2.66E-09 DEF8 
16 rs7195043 A G 0.50 88548362 0.72(0.64.0.80) 5.73E-09 DEF8 
16 rs11648898 A G 0.18 88573487 1.57(1.35-1.84) 1.46E-08 AFG3L1 
15 rs1129038 A G 0.22 26030454 0.70(0.61-0.79) 3.73E-08 HERC2 
16 rs4785752 A G 0.53 88562642 0.73(0.66-0.82) 4.14E-08 DEF8 
16 rs4785759 A C 0.53 88578381 0.73(0.66-0.82) 4.26E-08 AFG3L1 
15 rs12913832 A G 0.78 26039213 1.43(1.25-1.62) 6.15E-08 HERC2 
16 rs10852628 A G 0.31 88607428 1.40(1.24-1.58) 6.94E-08 DBNDD1 
9 rs6475552 A G 0.50 21691674 1.32(1.19-1.48) 3.71E-07 LOC402359 
9 SNP9-21789598 A G 0.49 21789598 0.75(0.68-0.84) 4.15E-07 MTAP 
9 rs7848524 A G 0.50 21691432 0.76(0.68-0.84) 4.28E-07 LOC402359 
16 rs4238833 A C 0.40 88578190 1.34(1.20-1.50) 4.56E-07 AFG3L1 
9 rs2383202 A G 0.49 21700215 1.32(1.19-1.47) 5.24E-07 LOC402359 
9 rs12380505 A G 0.50 21685893 0.76(0.68-0.85) 6.02E-07 LOC402359 
9 rs1335500 A G 0.49 21701675 1.32(1.18-1.47) 6.24E-07 LOC402359 
9 rs1452658 A G 0.50 21690795 1.32(1.18-1.47) 7.22E-07 LOC402359 
 
      To compare the performance of the NOIA statistical model with that of the usual functional 
model on a one-locus association study, we compared the top SNPs identified by these two models in 
a Manhattan plot (Fig. 2.7). The NOIA statistical model showed a highly significant signal in the 
HERC2 regions (Fig. 2.7a) at 15q13.1 whereas the usual functional model did not (Fig. 2.7b). The 
  
 
identification of the other two regions at 9p21.3 and 16q24.3 were similar for the two models. The 
results and signals we have reported so far are for the 
signal for the dominance effects
      We further applied the extended 
model (equation (15)) on the two
were incorporated. Attempting to identify potential SNPs that interacted with the two significant 
genes (HERC2 and MC1R) while contributing to the association with melanoma risk, w
rs1129038 and rs4785751, the two most significant SNPs, as the reference SNPs for the two
scan, respectively. We then performed a genome
reference SNPs separately and compared the performa
the usual functional model for detecting 
Figure 2.7 Manhattan plot for the genome
locus scan. Detection of the additive effect through (a) the NOIA statistical model and (b) the usual 
functional model. 
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      First, we performed the analysis for SNP rs1129038 in HERC2 region. For the additive effects 
evaluation, the NOIA statistical model still showed a strongly significant signal with P value in the 
1  10 significance level on the two significant regions adjacent to the MTAP and around MC1R  
genes, whereas the functional model had no obvious signal (Fig. 2.8a-b). Compared to the one-locus 
scan (Fig. 2.7a), the overall power for detecting the additive effect did not decrease in the NOIA 
two-locus model when more parameters were added in the model (Fig. 2.7a; 2.8a). This advantage 
did not emerge for the functional model (Fig. 2.7b; 2.8b). Moreover, no significant signal was 
observed for the dominant effects by either model (data not shown). For the four interaction terms, 
except the dominant-by-additive (da) interaction term, no obvious signal was identified by either 
model. A series of significant SNPs around gene IL31RA (interleukin-31 receptor A) and DDX4 on 
chromosome 5 were identified by the NOIA statistical model for interaction with rs1129038 at the 
dominant-by-additive interaction term (Fig. 2.8c), where the da term means the interaction between 
the additive effect of the rs1129038 and the dominant effect of the candidate interacted SNP. These 
signals were not identified by the usual functional model (Fig. 2.8d). We then checked the linkage 
disequilibrium (LD) status between the significant SNPs around the IL31RA gene and the significant 
SNPs around the DDX4 gene, showing that the two genes are in strong LD. 
      Table 2.3 presents the top SNPs interacted with rs1129038 at the  da interaction term analyzed 
by the NOIA statistical two-locus interaction model. Four SNPs near IL31RA and three SNPs near 
DDX4 were showing significant interaction with rs1129038 at the 1.0  10 significance level. 
However, other than the da interaction effect and the main additive effect from rs1129038, no main 
effects from the candidate interacted SNPs were identified.   
 
 
 
 
  
 
 
 
 
Figure 2.8 Manhattan plot for the genome
locus scan for rs1129038. Detection of the additive effect (
statistical model and (b) the usual functional model; detection of the dominant
effect (  and ) through (c) the NOIA statistical model and (d) the usual functional model. 
       
      Similarly, we compared the performance of the gene
that interacted with rs4785751 
statistical model and that of the usual functional model on detection of the main additive effects, the 
former still remained the signal for those identified strongly associated regions while the latter did 
not (Fig. 2.9). No interaction effects were ident
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Table 2.3 P values for the main effects and interaction effects when rs1129038 are used for reference 
SNP in the two-locus association analysis by NOIA statistical model (p  10).  Add=additive 
effect, Dom=dominant effect, Add-Add=additive-additive interaction effect, Dom-Add=dominant-
additive interaction effect; Add-Dom=additive-dominant interaction effect; Dom-Dom=dominant-
dominant interaction effect. Locus B is the reference SNP, rs1129038; Locus A is the candidate 
interacted SNP that scanned from the whole genome. 
 
CHR SNP Coordinate Gene Symbol 
P value 
Add_
A 
Dom_
A Add_B 
Dom_
B 
Add-
Add Dom-Add 
Add-
Dom 
Dom-
Dom 
5 rs6871296 55175024 LOC40221
6 
0.07 0.02 5.78E-08 0.46 0.45 1.06E-07 0.90 0.91 
5 rs3857290 55182187 IL31RA 0.08 0.03 6.26E-08 0.45 0.45 2.57E-07 0.87 0.83 
5 rs6876491 55181692 IL31RA 0.04 0.02 4.19E-08 0.33 0.47 5.37E-07 0.86 0.92 
5 rs10042075 55178483 IL31RA 0.03 0.01 3.01E-08 0.35 0.51 6.03E-07 0.86 0.73 
5 rs327240 55216666 IL31RA 0.02 0.25 2.61E-08 0.34 0.61 1.20E-06 0.75 0.27 
5 rs3843458 55090435 DDX4 0.03 0.12 6.69E-08 0.26 0.46 2.60E-06 0.70 0.60 
5 rs957459 55118231 DDX4 0.07 0.05 6.65E-08 0.28 0.46 2.92E-06 1.00 0.36 
5 rs10035707 55098280 DDX4 0.06 0.05 6.43E-08 0.28 0.46 4.07E-06 0.99 0.33 
10 rs12775320 78584174 KCNMA1 0.61 0.42 1.95E-07 0.00 0.50 6.58E-06 0.78 0.51 
4 rs6825100 17305532 KIAA1276 0.27 0.10 7.30E-08 0.15 0.49 9.49E-06 0.04 0.28 
 
      Finally, we also applied the reduced NOIA statistical model and the reduced usual functional 
model, the additive models (details shown in Appendix 2.1), for detecting the gene-gene interactions 
that contribute to melanoma risk.  For the second reference SNP, rs4785751, significant SNPs were 
identified for the additive-by-additive interaction effect (p value=7.07  10) by both the NOIA 
and usual additive models (Table 2.4). These SNPs are located in chromosome 4 close to gene 
PGRMC2.  
 
 
 
  
 
Figure 2.9 Manhattan plot for the genome
locus scan for rs4785751. Detection of the additive effect (
model and (b) the usual functional model.
 
Table 2.4 p values and estimates for the main effects and interaction effects when rs4785751 was 
used for reference SNP in the two
( ).   
 
CHR SNP Coordinate 
4 rs10009093 143849384 
4 rs10019366 129459033 
4 rs4975181 129466845 
4 rs11723210 129500895 
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-wide association studies of the CM susceptibility by two
 and ) through the NOIA statistical 
 
-locus association analysis by NOIA additive statisti
Gene 
Symbol 
Estimates 
Add_A Add_B Add-Add Add-A 
FLJ44477 0.08 0.37 -0.55 0.32 
PGRMC2 0.02 0.36 -0.44 0.76 
PGRMC2 0.10 0.37 -0.35 0.09 
PGRMC2 0.06 0.36 -0.45 0.44 
 
-
cal model 
P value 
Add_B Add-Add 
5.29E-11 7.07E-06 
1.09E-10 9.23E-06 
8.91E-11 9.71E-06 
1.24E-10 9.84E-06 
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2.3 Discussion 
      In most scenarios we simulated, the NOIA statistical model presented greater power for detecting 
additive effects and some interaction effects compared with the usual functional model. The NOIA 
model also yielded more precise estimators. Moreover, the investigation of type I error showed no 
significant difference of these two models. Real data analyses on the melanoma dataset also showed 
preference of the NOIA statistical model by one-locus and two-locus genome-wide scan. The 
epistasis analyses on the melanoma dataset showed that the NOIA statistical model preserved power 
for detecting the main genetic effects. The functional model lost power when multiple loci were 
jointly modeled. The NOIA statistical model identified potential epistasis between the rs1129038 
(located around HERC2 gene) and IL31RA gene while the functional model did not. Another 
significant region interacting with rs4785751 near MC1R gene was also identified, PGRMC2 located 
at 4q26, by the NOIA statistical additive model allowing gene-gene interactions.  
      On the other hand, by applying the additive one-locus NOIA model and usual functional model, 
we found that their performance for detecting the additive effect was the same. This can be explained 
by the theoretical evidence in Appendix 2.2. To further explore the reason why the NOIA model has 
preserved power on detecting the additive effect when the dominance component is included, 
whereas the usual model does not, we constructed the test statistic for each model in Appendix 2.2. 
From the test statistics shown there, we can clearly see the underlying mechanism is still related with 
the fact that the covariance between the additive and dominance component is not zero if the usual 
model is applied.  
      We also found another significant characteristic of the NOIA one-locus framework. Both the full 
NOIA and functional models are ill-conditioned if the SNP has only two or less genotypes in the 
population. This arose because of value of the determinant of the design matrix (XX) is equal to 
zero when the dominance component is included in the testing. For the additive models, the 
determinant of the design matrix is not equal to zero (Appendix 2.2). When the design matrix is 
noninvertible, one needs to use generalized inverses as another alternative in setting up the tests 
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rather than the inverse procedure that in R programming software. It has always been a problem in R 
that the inverse procedures are not robust. Therefore, in our Q-Q plots, the λ values were less than 
1(0.86~0.92) when performing NOIA or usual functional one-locus models with dominance 
component testing on melanoma dataset. After we removed the SNPs with minor genotype 
frequency less than 0.005, the λ values were 1.014 and 1.023 respectively (Fig. S2.11). According to 
our analyses, we suggest to apply the NOIA full model in two stratifications for one-locus scan of 
real data. NOIA full model is preferred for SNPs with three types of genotypes to identify potential 
dominant effects while maintaining the power to detect additive effects. Additive model would be 
better to be applied for those SNPs to get right distribution when they do not have all three 
genotypes. 
      In this section, we compared the NOIA statistical model and usual functional model for 
analyzing epistasis, or gene interactions, for quantitative traits and dichotomous diseases. These two 
models were able to be transformed to each other and they had different meaning for their 
parameters. The NOIA statistical model focuses on the population properties whereas the usual 
functional model focuses on the biological properties. The methodology of the NOIA statistical 
model was developed early in 2007 [21], however their performance on detecting gene-gene 
interactions has not been tested or compared with the other models.  
        For the real data analyses, the NOIA statistical one-locus model provided confirmatory 
evidence of the association of three previously identified causal regions with melanoma risk, HERC2 
at 15q13.1, MC1R at 16q24.3 and CDKN2A at 9p21.3. Compared to the NOIA statistical model, the 
usual functional one-locus model did not detect the most significant region, the HERC2 gene, which 
has been well characterized in the previous studies [8]. When we compare our analyzed results from 
the full usual functional model to those from the usual functional additive model (Fig. 2.7), we found 
that the HERC2 signal was detected very clearly by the usual additive model but not by the usual full 
model. Thus we conclude the NOIA full model has greater power than the usual functional model in 
one-locus genome-wide scans.  
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        The epistasis analyses showed that the power of the NOIA statistical model was greater than 
that of the usual functional model for detecting main genetic effects when interactions are included. 
When two loci and epistasis were modeled together, the usual functional model presented decreased 
power while the statistical model maintained its power for detecting the main genetic effects (Fig. 
2.8a). This result reflects one of the important properties of the NOIA model, orthogonality. Using 
orthogonal models for quantitative traits analysis or binary diseases yields consistent genetic effect 
estimation in reduced models. Here, we clearly see that the functional model had no consistent 
genetic effect estimation when multiple loci were modeled together.  
        Moreover, the NOIA statistical model identified potential epistasis between the rs1129038 
(located around HERC2) and a region at chromosome 5, whereas the functional model did not. This 
associated region is located in the 5’-UTR of IL31RA gene located at 5q11.2 and the intron of the 
gene DDX4 located at 5p15.2-p13.1. The expression of IL31RA is induced in activated monocytes 
and is constitutively expressed in epithelial cells. The interesting aspect of this interaction is that no 
main genetic effect was found for these SNPs. The interaction is based on the dominant-by-additive 
interaction term. Although it is hard to interpret the dominant-additive interaction term here, it is 
possible that only the reference locus (rs1129038) has a main effect while a significant interaction 
effect exists for gene-gene interaction models. Another significant region that interacted with 
rs4785751, PGRMC2 located at 4q26, was also identified, by the NOIA additive model. This is the 
first report of the implication of potential genes and regions that were shown to interact with SNPs 
associated with melanoma risk. If these interactions are confirmed by validation studies, there will be 
no doubt that the NOIA statistical model is preferred for epistasis detection compared to the usual 
functional model.  
        Whether there are factors that influence interaction effects without playing marginal/main 
effects has been a critical issue in genetic association studies [55]. In single-locus analysis, each 
locus is considered separately. Therefore, factors that influence interaction effects but not marginal 
effects will be missed, as they do not lead to marginal correlation between the genotype and outcome 
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phenotype. Our results highlight the application of NOIA interaction models for detecting both main 
and interaction effects, which could explain more heritability of human complex diseases. The usual 
functional models do not have this advantage because they may lose power when more parameters 
are added to the modeling. 
      Beyond two-locus interactions, we may also expect interaction of multiple loci, for instance, 
three-locus interactions. One may simply extend the full and additive NOIA statistical models by 
straightforwardly applying Kronecker products to additional loci. The NOIA three-locus interaction 
models on the significant SNPs contributing to the melanoma risk showed no signal for higher 
dimensional interactions. We also applied the three-locus interaction models on the significant SNPs 
contributing to lung cancer (the dataset we will use in next section) and we did not detect any three 
dimensional interactions. This may be because even less power is available to detect higher-order 
models. Large datasets will be required to estimate these parameters accurately. Interpreting the 
interactions is also complicated even for two-locus interactions. Validation from replication analysis 
and experiments to explain how these factors interact with each other is a challenging task. The 
underlying mechanism of the interactions may also difficult to explain. 
        The difference between the NOIA statistical model and the usual functional model lies in their 
focus. The former is characterized by orthogonal parameters that denote average effects of allele 
substitutions over population, whereas the latter focuses on the natural allele substitutions for 
parameter estimation. They are different viewpoints of a similar analysis. Nonetheless, when 
investigating the epistasis or gene-environment interactions, choosing the most appropriate 
framework is still important. We still recommend using the NOIA statistical model for epistasis 
study because of its greater power and its desired statistical properties. 
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CHAPTER 3 
Natural and Orthogonal Interaction Framework for Modeling Gene-Environment 
Interactions with Application to Lung Cancer 
 
      GWASs have not been effective in identifying much of the heritability of the human diseases as 
single SNP is isolated and analyzed by this approach. Much heritability has not been able to be 
explained especially when multiple loci or binary environmental exposure are jointly influencing 
disease risk. In the previous section, we formulized the NOIA orthogonal model on modeling joint 
contribution of multiple loci to the diseases development or quantitative levels of a trait.  In this 
section, we propose to develop a statistical approach for modeling effects from genetic factors and 
environmental exposure, from the orthogonal NOIA model. We included a binary environmental 
exposure and its interaction with gene in the modeling of a quantitative trait. We evaluated the 
performance of the newly developed NOIA gene-environment (GxE) interaction model by 
comparing its statistical behavior with the usual models on simulated datasets for quantitative traits.  
We also explored the possibility of generalizing the orthogonal models to the analysis of 
binary traits, such as diseases. We found that the meaning of orthogonality is somewhat 
different on the log-odds scale than its original meaning for a quantitative trait: although the 
estimators are no longer orthogonal, the variance decomposition remains orthogonal when 
the log-odds are simply treated as genetic effects under the alternative hypothesis of an 
effect in the NOIA formulation. Our simulation results showed that for both quantitative and 
qualitative traits, the statistical models have higher power than the usual functional ones in 
most of the scenarios we have tested. Used with permission from S. Karger AG, Basel, Ma J. 
et al: Hum Hered 2012; 73: 185–194. [22] 
 
      We then applied the NOIA GxE modeling on a real lung cancer dataset. As widely known, 
smoking is by far the main risk factor of lung cancer as well as genetic factors. Previous studies have 
identified three chromosomal regions at 15q25, 5p15 and 6p21 as being significantly associated with 
the susceptibility of lung cancer [8, 56-58]. Replication studies then indicated interaction of smoking 
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and 15q25 variants in predisposing white populations to lung cancer susceptibility [59]. Our 
motivation is to validate the potential causal variants of lung cancer risk and identify potential 
interactions between these variants and smoking through the newly developed approach. In 
following sections, the performance of the usual functional model and NOIA statistical model will 
also be evaluated for the testing of effects from genetic factors and smoking exposure in full models 
and reduced models. 
 
3.1 Methods 
3.1.1 Methodology Development of the NOIA Gene-Environment Interaction Model 
  One-locus Model 
      We already introduced the one-locus usual functional model and NOIA statistical model in 
Chapter One.  
      As shown in Alvarez-Castro and Carlborg, this statistical model is orthogonal, meaning 
that estimates of these parameters are uncorrelated. The orthogonality of the statistical model 
is also reflected by the fact that the variance of G can be decomposed into those of the 
additive and dominant components. [22]  
      For the analysis of case-control data sampled according to a qualitative trait such as a 
disease, we can define a similar statistical model by treating the genotypic values and the 
genetic effects as the logit (i.e. logarithm of the odds) of the disease. However, two 
important features of the orthogonal models may no long be valid here. First, the estimates 
of parameters using logistic regression are not uncorrelated. Recall that the variance of 
estimates of parameters for linear regression can be expressed as VarCβD  σCχχD, 
where χ  is the design matrix, as far as the error terms for all samples are independent and 
identically distributed with variance σ2, which can be shown to be diagonal for the statistical 
model. However, for logistic regression, the variance of estimates of parameters is VarCβD  σCχνχD, 
where ν is a diagonal matrix with elements πGJ1 2 πGK 
for the i-th individual in the sample with πG the probability of being affected given the 
values of repressor for the individual.  It can be shown that XV X   nSDS, 
where 
DE  5πC1 2  πDp 0 00 πC1 2  πDp 00 0 πC1 2 πDp;, 
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and S is a design matrix. This means that, for logistic regression, the statistical model 
defined in equation (5) has no orthogonal estimates as in the case of linear regression, unless 
the gene is not associated with the disease (π would then assume the same values for all 
genotypes). Second, as will be shown later, the estimates of main effects for a full interaction 
model is no longer the same as the corresponding effects of the reduced models, i.e., the 
single-locus model and the environment-only models. Nevertheless, the orthogonal 
decomposition of variance is still valid here on the log-odds scale. We will therefore apply 
this model to the analysis of case-control data. We will hereafter use a common terminology, 
statistical model, for both quantitative and qualitative trait, and evaluate its performance in 
simulation studies. We do not explicitly model the influence of the genotype frequencies on 
the variance of the regression parameters in logistic regression. We extended the 
formulations for the statistical and functional models to the following three reduced genetic 
models: additive, dominant, and recessive. Used with permission from S. Karger AG, Basel, 
Ma J. et al: Hum Hered 2012; 73: 185–194. [22] 
 
  Gene- Environment Interaction 
      Suppose we have a binary environmental exposure, M, with phenotypic values M and M for unexposed and exposed individuals, respectively. We denote the unexposed 
frequency by m. A functional model for this environmental exposure is Mrrrs  cMMd  g1 01 1h c Rad, 
with effects defined as Ers  c Rad  g 1 021 1h cMMd. 
      For a two-level factor, following Alvarez-Castro and Carlborg, the criterion for 
orthogonality can be derived as follows: from the regression model 
1M
M%M 3  1
1 00 1% %0 13 c
MMd   SErs  XErs, 
orthogonality requires that XX   nSZZ S   SDS 
is diagonal, where D  cm 00 md, 
and m  m and m  1 2 m are the exposure frequencies. Since XX  n < ms  ms mss  mssmss  mss ms  ms @. 
It follows that the model S is orthogonal when mss  mss  0. 
      Using this criterion, we find that the functional model given above is not 
orthogonal.  
      The orthogonal (or statistical) model for the binary environmental factor is  Mrrrs  cMMd  g1 m 2 11 m h g µαh, 
with effects defined as Ers  g µαh  g m 1 2 m21 1 h cMMd. 
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      Applying the Kronecker product rule, we have the following non-orthogonal functional 
model for the gene-environment interaction:  
Grs 
"
###
##$
GMGMGMGMGMGM&
'''
''( 
"
###
##$
1 0 0 0 0 01 1 1 0 0 01 2 0 0 0 01 0 0 1 0 01 1 1 1 1 11 2 0 1 2 0&
'''
''(
"
###
##$
Radaaada&
'''
''(
, 
and the following statistical model: 
Grs 
"
###
###
$1 2N7 2 bW`b``I m 2 1 2Cm 2 1DN7 2 bW`b``I1 1 2 N7 
bWWb``I m 2 1 Cm 2 1DC1 2 N7D 
bWWb``I1 2 2 N7 2 bWWbW`I m 2 1 Cm 2 1DC2 2 N7D 2 bWWbW`I1 2N7 2 bW`b``I m 2m 2 bW`b``I1 1 2 N7 
bWWb``I m mC1 2 N7D 
bWWb``I1 2 2 N7 2 bWWbW`I m mC2 2 N7D 2 bWWbW`I &
'''
'''
(
"
###
#$
µαδαααδα&
'''
'(
. 
The relation between the statistical and functional models is 
 
"
###
#$
µαδαααδα&
'''
'( 
"
###
##$
1 N7 p 1 2 m C1 2 mDN7 C1 2 mDp0 1 p 0 1 2 m C1 2 mDp0 0 1 0 0 1 2 m0 0 0 1 N7 p0 0 0 0 1 p0 0 0 0 0 1 &
'''
''(
"
###
##$
Radaaada&
'''
''(
. [22]  
The formulation of the three reduced genetic models of the statistical and functional GxE 
and their relationships are shown in the supplementary text in Ma et al. Used with 
permission from S. Karger AG, Basel, Ma J. et al: Hum Hered 2012; 73: 185–194. [22] 
 
3.1.2 Simulation Studies on Quantitative Traits and Qualitative Traits 
      The simulation methods we are using in this section are similar to the simulation methods we 
mentioned in Chapter 2 for GxG interactions. Here, we set the exposed frequency m to be 0.22 for 
the simulated population. The allele frequencies (p) for the SNP were set to 0.30. Genotype 111, 
121, 221, 112, 122, or 222 were assigned to an individual with probabilities C1 2 pDC1 2 mD, 
2pC1 2 pDC1 2 mD, pC1 2 mD, C1 2 pDm 2pC1 2 pDm or pm respectively. From a prespecified 
vector of parameters, Ers.  R, aG, dG, aM , aa, da, we assigned each individual a phenotypic value 
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according to his/her assigned one locus genotypes and exposure status. Then, by randomly 
generating a value from a normal distributions with prespecified mean and variance (0 and σS ), we 
generated an observed phenotype/trait by adding this residual to the previously assigned phenotypic 
value. The residual variance σS was 144.0. We used data from 2000 individuals as a replicate and 
simulated 1000 replicates for each genetic model.  
      In our investigation of quantitative traits, two scenarios were simulated with different effects 
terms.  
      We simulated case-control data with both main and interaction effects using the logistic 
models. If the risk of disease is determined by a diallelic gene and a binary exposure, we 
assume that the penetrance model is given by PrCd  1|iD  fSbCGD ,  
where d  1 denotes  that fact  that an  individual  is affected  and  G  is the genotypic  
value when the joint genotype is i with i = 111, 121, 221, 112, 122, or 222. Using Bayes’ 
theorem, we have the distributions of the six genotypes in the cases as follows PrCi|d  1D  G/JfSbCGDK∑ H/gfSbJHKhH  , 
where P  is the frequency of genotype  i in the population, given by C1 2 pDC1 2 mD, 2pC1 2 pDC1 2 mD, pC1 2 mD, C1 2 pDm 2pC1 2 pDm or pm, respectively, as in the 
simulation of a quantitative trait. Given the genotypic values and the frequencies of the joint 
genotypes, this expression was used for simulating joint genotypes of cases. For the 
simulation of controls, we have a similar expression: PrCi|d  0D  G/JfSbCGDK∑ H/gfSbJHKhH  . 
The genotypic values were determined from pre-specified genetic effects, Ers. It should be 
noted that, unlike the simulated data for a quantitative trait, not only the allele frequencies, 
but also the genetic effects, in the simulated case-control data are usually different from the 
corresponding pre-specified values (population parameters) because of ascertainment bias. 
Used with permission from S. Karger AG, Basel, Ma J. et al: Hum Hered 2012; 73: 185–
194. [22] 
 
      For the case-control trait, two scenarios were simulated with different effects terms. The minor 
allele frequencies for the markers were set to 0.25. The unexposed frequency was set to 0.22. The 
residual variance σS was 144.0. We used data from 2000 individuals as a replicate and simulated 
1000 replicates for each genetic model. 
3.1.3 Application on Lung Cancer Susceptibility 
      We applied the NOIA statistical model and the usual functional model to the ILCCO 
(International lung cancer consortium) data, consisting of 17 independent case-control 
  
41 
 
studies (most but not all of the original studies agreed to participate in this study). The 
objectives of the consortium are to share data to increase statistical power, reduce 
duplication of research efforts, replicate novel findings, and realize substantial cost savings. 
Details of the participating studies have been described previously [59]. Our goal here was to 
examine how genetic variants, which have been identified through GWAS, may interact with 
smoking in determining the risk of lung cancer by pooling the datasets. Here, we focused on 
six SNPs in three regions: rs2736100 and rs402710 (5p15), rs2256543 and rs4324798 
(6p21), and rs16969968 and rs8034191 (15q25). Our analysis included 17836 Caucasians 
with 7392 cases and 10444 controls after quality control. For both NOIA statistical model 
and the usual functional model, logistic regression was performed with sex, age and study 
group as covariates. Used with permission from S. Karger AG, Basel, Ma J. et al: Hum 
Hered 2012; 73: 185–194. [22] 
 
      A wald test was performed for the null hypothesis test that there is no association. The testing 
models can be generally shown as following, 
Logit (qualitative trait) = β0 + β1*G + β2*E + β3*GxE + sex + age+D+…+D. 
In the above expression, G denotes the genetic value;  denotes the environmental exposure value 
which is cigarettes smoking status here (0 for non-smokers and 1 for smokers); GxE is for the 
interaction values between the genetic effect and environmental effect.  D (i=1, 2…16) is the 
dummy variable for the independent study groups. For both the NOIA statistical models and the 
usual functional models, logistic regression was performed, with sex, age and study group as 
covariates. We applied the full models including GxE interactions testing, the reduced models 
including GxE interactions testing, the full models without GxE interactions testing and the additive 
models without GxE interactions testing to the ILCCO dataset. 
 
3.2 Results 
3.2.1 Simulation Studies on Quantitative Traits and Qualitative Traits 
       We conducted extensive simulation analyses on both simulated quantitative traits and case-
control traits.  First, we performed simulation studies on a quantitative trait under two scenarios. The 
pre-specified minor allele frequency and exposure frequency was 0.30 and 0.22 respectively. The 
simulating residual variance was 144.0.  
  
42 
 
      Our first simulation exhibited both effects from the gene and the environmental factor along with 
the interactions. The true effect values were 
Ers.  R, a, d , a, aa, da   100.0,  3.0,  1.0,  2.0,  1.5,  1.0. The corresponding statistical 
genetic effects values Ers4could then be calculated by the minor allele frequency, exposure frequency 
and the actual functional terms. Then, we got 
Ers4  μ, α, δ , α, αα, δα  101.75,  4.18,  1.22,  2.71,  2.2,  1.0. Figure 3.1 illustrates the 
power of the NOIA statistical model and usual functional model on detecting the effects from the 
genetic factor including the additive and dominant effects, the environmental exposure, and the 
additive-by-environment interaction. For detecting the main genetic effects and environmental 
effects, the NOIA statistical model clearly showed greater power than the usual functional model, 
especially for additive effects (Fig. 3.1, upper panel and left bottom panel). The NOIA statistical 
model also exhibited slightly greater power than the usual functional model for detecting the 
interaction effects (Fig. 3.1, right bottom panel). The density distribution of the parameters estimated 
from these replicates was shown in Figure S3.1. Clearly, the variance of the genetic additive effect 
and interaction effect estimated from the NOIA statistical model was much smaller than that from 
the usual functional model (Fig. S3.1). The variance of the other effects estimated from these two 
models was very close to each other. Furthermore, the estimations of the genetic effects were both 
accurate for the two models, as the peaks were all located around the simulated true values (Fig. S3. 
1).  
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Figure 3.1 Power under different critical values of the P values obtained using the Wald test for the 
simulated data with a quantitative trait influenced by a genetic factor and an environmental factor. 
The pre-specified minor allele frequency and exposure frequency was 0.30 and 0.22 respectively. 
The simulating residual variance was 144.0. The values of the six parameters of the genetic 
effects were Ers.   100.0,  3.0,  1.0,  2.0,  1.5,  1.0. The corresponding statistical genetic effects 
were Ers4  101.75,  4.18,  1.22,  2.71,  2.2,  1.0.  
 
      Another simulation was performed for a scenario where a quantitative trait is only influenced 
by a genetic factor. The true effect values were Ers.   100.0,  3.0,  1.0,  0.0,  0.0,  0.0. The 
corresponding statistical genetic effects were Ers4  101.16,  3.70,1.00,0.00,0.00,0.00. Figure 
3.2 shows the power of the NOIA statistical model and usual functional model on detecting the 
genetic effects, the environmental effect, and additive-by-environment interaction effect. For 
detecting the genetic additive effect, the NOIA statistical model clearly had greater power than 
the usual functional model (Fig. 3.2, upper left panel). For the other two parameters, the false 
positive rates were very close to the nominal level for both the NOIA statistical model and usual 
model (Fig. 3.2, bottom panel). The density distribution of the parameters estimated from these 
replicates was shown in Figure S3.2.  
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Figure 3.2 Power under different critical values of the P values obtained using the Wald test for 
the simulated data with a quantitative trait influenced by a genetic factor. The pre-specified minor 
allele frequency and exposure frequency was 0.30 and 0.22 respectively. The simulating 
residual variance was 144.0. The values of the six parameters of the genetic effects were Ers.   100.0,  3.0,  1.0,  0.0,  0.0,  0.0. The corresponding statistical genetic effects were Ers4  101.16,  3.70,1.00,0.00,0.00,0.00.  
 
      Figures 3.3-3.4 show the results obtained from the case-control trait simulations. For the scenario 
when both a genetic factor and an environment factor influence the trait, the true effect values were 
22.0,  0.3,  0.1,  0.2,  0.1,  0.04. The corresponding statistical genetic effects were 
21.75,  0.38,  0.11,  0.27,  0.12,  0.04. Figure 3.3 shows that for detecting the main genetic effects 
and environmental effects, the NOIA statistical model clearly had greater power than the usual 
functional model, especially for additive effects (Fig. 3.3). The NOIA statistical model also exhibited 
slightly greater power than the usual functional model for detecting the interaction effects (Fig. 3.3, 
right bottom panel). The density distribution of the parameters estimated from these replicates was 
shown in Figure S3.3. Still, the variance of the genetic additive effect, environmental effect and 
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additive-by-environment interaction effect estimated from the NOIA statistical model was much 
smaller than that from the usual functional model (Fig. S3. 3).  
 
Figure 3.3 Power under different critical values of the P values obtained using the Wald test for the 
simulated data with a case-control trait influenced by a genetic factor and an environmental factor. 
The pre-specified minor allele frequency and exposure frequency was 0.25 and 0.22 respectively. 
The values of the six parameters of the genetic effects were Ers. 22.0,  0.3,  0.1,  0.2,  0.1,  0.04. The corresponding statistical genetic effects were Ers4 21.75,  0.38,  0.11,  0.27,  0.12,  0.04.  
 
      For the scenario when only a genetic factor influences the case-control trait (Fig. 3.4), the true 
effect values were 22.0,  0.4,  0.2,  0.0,  0.0,  0.0. The corresponding statistical genetic effects were 
21.73,  0.5,  0.2,  0.0,  0.0,  0.0. For detecting the genetic effect, the NOIA statistical model clearly 
had greater power than the usual functional model, especially for the additive effect (Fig. 3.4, upper 
panel). For the other two parameters, the false positive rates were very close to the nominal level for 
both the NOIA statistical model and usual model (Fig. 3.4, bottom panel). The density distribution of 
the parameters estimated from these replicates was shown in Figure S3.4. 
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Figure 3.4 Power under different critical values of the P values obtained using the Wald test for the 
simulated data with a case-control trait influenced by a genetic factor. The pre-specified minor allele 
frequency and exposure frequency was 0.25 and 0.22 respectively. The values of the six parameters 
of the genetic effects were Ers.  22.0,  0.4,  0.2,  0.0,  0.0,  0.0. The corresponding statistical 
genetic effects were Ers4  21.73,  0.5,  0.2,  0.0,  0.0,  0.0.  
 
      To evaluate the false positive rate of the two models, we also simulated a null scenario where 
no any effect influences the quantitative trait. The false positive rates of the NOIA statistical 
model in the 0.05 significance level for detecting the five effects are: 0.058, 0.053, 0.043, 0.052 
and 0.049. The false positive rates of the usual functional model for detecting the five effects are: 
0.058, 0.058, 0.061, 0.055 and 0.05. They are very close to the nominal level for both models. For 
the qualitative traits, the false positive rates of the NOIA statistical model in the 0.05 significance 
level for detecting the five effects are: 0.047, 0.045, 0.047, 0.052 and 0.052. The false positive 
rates of the usual functional model for detecting the five effects are: 0.06, 0.05, 0.059, 0.058 and 
0.052. The functional model has slightly higher false positive rates than the NOIA statistical 
model when applied on qualitative traits. 
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3.2.2 Application of the NOIA Model on Lung Cancer Susceptibility 
      Next, we conducted real data analyses by applying the NOIA statistical model and usual 
functional model to the ILCCO dataset. The statistics of the samples and the summary of the 
SNPs that we used in ILCCO dataset are shown in Table S3.1 and Table S3.2, respectively. There 
are about 41% females and 59% males in cases, 48% females and 52% males in controls. The 
distribution of the age and smoking status among cases and controls are also shown in Table S3.1. 
The risk allele and the minor allele frequencies for the 6 SNPs under investigation are shown in 
Table S3.2. We mainly focus on the three chromosomal regions (5p15, 6p21 and 15q25), 
including 6 potential causal variants. First, to evaluate the performance of the NOIA statistical 
model and usual functional model, we applied the additive models with no interaction effects 
testing to the dataset. The odds ratio with 95% confidence intervals and P values estimated from 
the NOIA statistical model and usual functional model are shown in Table 3.1. The two models 
had similar performance on detecting the genetic additive effect and smoking exposure effect. 
Consistent with previously published results, both models detected significant additive effects 
from 5p15 and 15q25. Table 3.2 shows the results when additive-by-smoking (Add-SM) 
interaction effect is incorporated in the models. Both models identified potential Add-SM 
interactions from the rs2256543 on 6p21 and the two SNPs on 15q25 predisposing to the lung 
cancer risk. The NOIA statistical (NOIA-Stat) model showed greater power on detecting the 
additive effect and same power on detecting the Add-SM interaction effect than the usual 
functional (Usual-Func) model. Comparing Table 3.1 and Table 3.2, we clearly state that after the 
Add-SM interaction term is added into the modeling, the additive Usual-Func model has 
extremely larger P values on detecting the additive effect than those obtained before, whereas the 
additive NOIA-Stat model preserved the power.       
      We then attempted to apply the full NOIA-Stat model with dominance component and the full 
Usual-Func model with dominance component to the ILCCO dataset. First, we performed the full 
models without GxE interactions testing. Table 3.3 illustrates the odds ratio with 95% confidence 
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intervals and P values. The full NOIA-Stat model and Usual-Func model had close coefficient 
estimators and P values on testing the significant additive effects from 5p15 and 15q25. Still, the 
P values estimated from the full NOIA-Stat model were slightly smaller than those from the full 
Usual-Func model. Moreover, we performed the full NOIA-Stat and Usual-Func models in which 
testing for additive effects, dominant effects and GxE interactions were incorporated on the real 
dataset (Table 3.4). Only the NOIA-Stat model identified potential Add-SM interactions from the 
rs2256543 on 6p21 contributing to the lung cancer risk. Both models identified the Add-SM 
interactions from the two SNPs on 15q25. Again, the full NOIA-Stat model showed greater 
power for detecting the additive effect compared to the full Usual-Func model. 
      To further validate the potential interaction effects of the two SNPs on 15q25 with smoking 
exposure, we performed stratified analyses on this dataset. First, we stratified the samples into 
two sub-populations: non-smokers and smokers. Then, we used (0, 1, 2) coding for the additive 
effect testing. We used sex, ages, study groups as covariates. The 95% confidence interval of the 
OR and P values are shown in Table 3.5. We can clearly state that the two SNPs on 15q25 are 
extremely significant in smokers (P value=2.08  10Nfor rs16969968, P value=2.50  10 
for rs8034191) contributing to lung cancer susceptibility. And the two SNPs are not significant in 
non-smokers. 
      For all SNPs and all models, the smoking effect was extremely significant. None of the SNPs 
had significant dominant effect or dominant-smoking interaction effect by any model. For all 
models, the estimation of the effect of sex and age were consistent because they were modeled in 
the same way. Furthermore, to explore whether there are any potential GxG interactions among 
these six SNPs predisposing white population to lung cancer, we performed the GxG models that 
mentioned in Chapter 2 on the ILCCO dataset. No interactions were identified (data not shown).
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Table 3.1 Odds ratio and P values estimated from additive models when there were no interactions modeled a. 
 
 
  
OR(95% CI) p value 
SNPs Model b Add SM Sex Age Add SM Sex Age 
rs2736100_5p15 Func/Stat 1.17(1.11-1.23) 5.99(5.42-6.63) 1.26(1.16-1.36) 1.01(1.01-1.02) 2.9E-10 8.9E-268 8.8E-09 1.5E-16 
rs402710_5p15 Func/Stat 0.86(0.81-0.90) 6.02(5.42-6.69) 1.26(1.16-1.36) 1.01(1.01-1.02) 7.7E-09 1.5E-244 6.8E-09 3.1E-37 
rs2256543_6p21 Func/Stat 1.03(0.98-1.08) 5.99(5.43-6.62) 1.25(1.16-1.35) 1.01(1.01-1.02) 0.23 1.2E-271 8.2E-09 6.0E-16 
rs4324798_6q21 Func/Stat 1.12(0.95-1.32) 5.93(5.37-6.55) 1.23(1.14-1.32) 1.02(1.02-1.02) 0.28 3.4E-270 3.0E-08 6.1E-29 
rs16969968_15q25 Func/Stat 1.25(1.19-1.31) 5.86(5.31-6.48) 1.23(1.14-1.32) 1.02(1.01-1.02) 1.3E-19 9.3E-266 3.5E-08 4.7E-28 
rs8034191_15q25 Func/Stat 1.29(1.22-1.36) 5.11(4.50-5.81) 1.29(1.19-1.40) 1.02(1.02-1.03) 1.4E-19 1.2E-136 2.6E-09 3.2E-33 
     a. The study group has been used as covariates. Add=Additive effect; SM=smoking;  
     b. Func=The usual functional model; Stat=The NOIA statistical model. 
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Table 3.2 Odds ratio and P values estimated from additive models when interactions were modeled a 
 
 
  
OR(95% CI) p value 
SNPs Model b Add SM Add-SM Sex Age Add SM Add-SM Sex Age 
rs2736100_5p15 
Usual-Func 1.23(1.10-1.39) 6.02(5.45-6.67) 0.94(0.82-1.07) 1.26(1.16-1.36) 1.01(1.01-1.02) 0.0005 1.6E-265 0.33 9.0E-09 1.6E-16 
NOIA-Stat 1.18(1.12-1.24) 6.00(5.43-6.64) 0.94(0.82-1.07) 1.26(1.16-1.36) 1.01(1.01-1.02) 1.9E-10 2.2E-267 0.33 9.0E-09 1.6E-16 
rs402710_5p15 
Usual-Func 0.88(0.76-1.00) 5.96(5.31-6.71) 0.97(0.84-1.13) 1.26(1.17-1.36) 1.02(1.02-1.03) 0.055 1.2E-195 0.73 7.0E-09 3.1E-37 
NOIA-Stat 0.86(0.81-0.91) 6.01(5.41-6.68) 0.97(0.84-1.13) 1.26(1.17-1.36) 1.02(1.02-1.03) 2.3E-08 4.3E-244 0.73 7.0E-09 3.1E-37 
rs2256543_6p21 
Usual-Func 0.92(0.81-1.03) 6.10(5.52-6.76) 1.15(1.01-1.31) 1.26(1.16-1.36) 1.01(1.01-1.02) 0.15 2.4E-267 0.036 6.6E-09 5.2E-16 
NOIA-Stat 1.02(0.97-1.07) 6.00(5.44-6.64) 1.15(1.01-1.31) 1.26(1.16-1.36) 1.01(1.01-1.02) 0.47 1.2E-271 0.036 6.6E-09 5.2E-16 
rs4324798_6q21 
Usual-Func 1.07(0.64-1.64) 5.80(5.22-6.47) 1.05(0.66-1.80) 1.23(1.14-1.32) 1.02(1.02-1.02) 0.60 3.0E-66 0.31 3.0E-08 6.2E-29 
NOIA-Stat 1.04(0.95-1.12) 5.94(5.38-6.56) 1.12(0.89-1.41) 1.23(1.14-1.32) 1.02(1.02-1.02) 0.42 2.8E-270 0.31 3.0E-08 6.2E-29 
rs16969968_15q25 Usual-Func 1.00(0.88-1.13) 6.29(5.66-7.01) 1.31(1.14-1.49) 1.23(1.14-1.32) 1.02(1.02-1.02) 0.99 4.0E-249 0.0001 3.7E-08 2.7E-28 
NOIA-Stat 1.23(1.17-1.29) 5.87(5.32-6.49) 1.31(1.14-1.50) 1.23(1.14-1.32) 1.02(1.02-1.02) 9.2E-16 4.9E-266 0.0001 3.7E-08 2.7E-28 
rs8034191_15q25 
Usual-Func 1.02(0.86-1.21) 5.43(4.74-6.24) 1.29(1.08-1.55) 1.29(1.19-1.41) 1.02(1.02-1.03) 0.79 1.9E-128 0.0057 2.3E-09 1.9E-33 
NOIA-Stat 1.26(1.19-1.33) 5.09(4.48-5.80) 1.29(1.08-1.55) 1.29(1.19-1.41) 1.02(1.02-1.03) 3.1E-15 1.8E-136 0.0057 2.3E-09 1.9E-33 
      a. The study group has been used as covariates. Add=Additive effect; SM=smoking. 
      b. Usual-Func=The usual functional model; NOIA-Stat=The NOIA statistical model. 
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Table 3.3 Odds ratio and P values estimated from full models when no interactions were modeled a 
 
 
  
OR(95% CI) p value 
SNPs Model b Add Domi SM Sex Age Add Domi SM Sex Age 
rs2736100_5p15 
Usual-Func 1.17(1.11-1.23) 1.00(0.93-1.07) 5.99(5.42-6.63) 1.26(1.16-1.36) 1.01(1.01-1.02) 3.4E-10 0.95 1.0E-267 8.8E-09 1.5E-16 
NOIA-Stat 1.17(1.11-1.23) 1.00(0.93-1.07) 5.99(5.42-6.63) 1.26(1.16-1.36) 1.01(1.01-1.02) 2.9E-10 0.95 1.0E-267 8.8E-09 1.5E-16 
rs402710_5p15 
Usual-Func 0.86(0.81-0.90) 0.99(0.91-1.07) 6.01(5.42-6.69) 1.26(1.16-1.36) 1.01(1.01-1.02) 4.0E-07 0.79 1.5E-244 6.8E-09 3.1E-37 
NOIA-Stat 0.86(0.81-0.90) 0.99(0.91-1.07) 6.01(5.42-6.69) 1.26(1.16-1.36) 1.01(1.01-1.02) 7.7E-09 0.79 1.5E-244 6.8E-09 3.1E-37 
rs2256543_6p21 
Usual-Func 1.03(0.98-1.08) 1.02(0.95-1.09) 5.99(5.43-6.62) 1.25(1.16-1.35) 1.01(1.01-1.02) 0.28 0.55 1.1E-271 8.1E-09 5.9E-16 
NOIA-Stat 1.03(0.98-1.08) 1.02(0.95-1.09) 5.99(5.43-6.62) 1.25(1.16-1.35) 1.01(1.01-1.02) 0.23 0.55 1.1E-271 8.1E-09 5.9E-16 
rs4324798_6q21 
Usual-Func 1.12(0.95-1.32) 0.92(0.77-1.11) 5.93(5.37-6.55) 1.23(1.14-1.32) 1.02(1.02-1.02) 0.19 0.38 3.6E-270 2.9E-08 5.9E-29 
NOIA-Stat 1.05(0.97-1.13) 0.92(0.77-1.11) 5.93(5.37-6.55) 1.23(1.14-1.32) 1.02(1.02-1.02) 0.27 0.38 3.6E-270 2.9E-08 5.9E-29 
rs16969968_15q25 
Usual-Func 1.23(1.17-1.30) 1.06(0.99-1.14) 5.86(5.31-6.48) 1.23(1.14-1.32) 1.02(1.01-1.02) 1.3E-15 0.10 1.0E-265 3.9E-08 5.7E-28 
NOIA-Stat 1.25(1.19-1.31) 1.06(0.99-1.14) 5.86(5.31-6.48) 1.23(1.14-1.32) 1.02(1.01-1.02) 9.6E-20 0.10 1.0E-265 3.9E-08 5.7E-28 
rs8034191_15q25 
Usual-Func 1.27(1.20-1.35) 1.05(0.97-1.13) 5.11(4.50-5.81) 1.29(1.19-1.40) 1.02(1.02-1.03) 1.5E-16 0.26 9.7E-137 2.7E-09 3.6E-33 
NOIA-Stat 1.29(1.22-1.36) 1.05(0.97-1.13) 5.11(4.50-5.81) 1.29(1.19-1.40) 1.02(1.02-1.03) 1.1E-19 0.26 9.7E-137 2.7E-09 3.6E-33 
a. The study group has been used as covariates. Add=Additive effect; Dom=Dominant effect; SM=smoking. 
b. Usual-Func=The usual functional model; NOIA-Stat=The NOIA statistical model. 
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Table 3.4 Odds ratio and P values estimated from full models when interactions were modeled a 
 
  
OR(95% CI) p value 
SNPs Model 
b
Add Domi SM Add_SM Domi_SM Sex Age Add Domi SM Add_SM Domi_SM Sex Age 
rs2736100_5p1
5 
Usual-
Func 
1.24(1.10-
1.40) 
1.03(0.87-
1.23) 
6.14(5.37-
7.05) 
0.93(0.82-
1.07) 
0.96(0.80-
1.16) 
1.25(1.16-
1.36) 
1.01(1.01-
1.02) 0.0005 0.71 3.24E-149 0.3105 0.67 9.07E-09 1.66E-16 
NOIA-
Stat 
1.18(1.12-
1.24) 
1.00(0.93-
1.07) 
6.00(5.43-
6.64) 
0.94(0.82-
1.07) 
0.96(0.80-
1.16) 
1.25(1.16-
1.36) 
1.01(1.01-
1.02) 1.9E-10 0.97 3.50E-267 0.3212 0.67 9.07E-09 1.66E-16 
rs402710_5p15 
Usual-
Func 
0.87(0.75-
1.02) 
1.00(0.82-
1.23) 
6.02(5.08-
7.16) 
0.98(0.83-
1.16) 
0.98(0.79-
1.22) 
1.26(1.17-
1.36) 
1.02(1.02-
1.03) 0.0880 0.97 1.35E-93 0.8131 0.88 6.98E-09 3.13E-37 
NOIA-
Stat 
0.86(0.81-
0.91) 
0.99(0.91-
1.07) 
6.01(5.41-
6.68) 
0.97(0.84-
1.13) 
0.98(0.79-
1.22) 
1.26(1.17-
1.36) 
1.02(1.02-
1.03) 2.29E-08 0.82 4.43E-244 0.7312 0.88 6.98E-09 3.13E-37 
rs2256543_6p2
1 
Usual-
Func 
0.92(0.82-
1.04) 
0.95(0.80-
1.13) 
5.84(5.09-
6.71) 
1.14(1.00-
1.30) 
1.09(0.91-
1.32) 
1.26(1.16-
1.36) 
1.01(1.01-
1.02) 0.1950 0.55 3.99E-138 0.0579 0.36 6.56E-09 4.90E-16 
NOIA-
Stat 
1.02(0.97-
1.07) 
1.01(0.95-
1.09) 
6.00(5.44-
6.64) 
1.15(1.01-
1.31) 
1.09(0.91-
1.32) 
1.26(1.16-
1.36) 
1.01(1.01-
1.02) 0.4594 0.68 1.18E-271 0.0370 0.36 6.56E-09 4.90E-16 
rs4324798_6q2
1 
Usual-
Func 
1.07(0.64-
1.64) 
0.86(0.53-
1.49) 
6.11(3.83-
10.46) 
1.05(0.66-
1.80) 
1.08(0.61-
1.82) 
1.23(1.14-
1.32) 
1.02(1.02-
1.02) 0.7826 0.57 8.06E-13 0.8370 0.78 2.91E-08 5.87E-29 
NOIA-
Stat 
1.04(0.95-
1.12) 
0.92(0.76-
1.11) 
5.94(5.38-
6.56) 
1.12(0.89-
1.41) 
1.08(0.61-
1.82) 
1.23(1.14-
1.32) 
1.02(1.02-
1.02) 0.4027 0.37 2.90E-270 0.3322 0.78 2.91E-08 5.87E-29 
rs16969968_15
q25 
Usual-
Func 
1.00(0.87-
1.14) 
1.01(0.84-
1.22) 
6.10(5.25-
7.11) 
1.29(1.11-
1.49) 
1.06(0.87-
1.30) 
1.23(1.14-
1.32) 
1.02(1.02-
1.02) 0.9511 0.91 3.69E-121 0.0007 0.56 4.13E-08 3.48E-28 
NOIA-
Stat 
1.23(1.17-
1.29) 
1.06(0.98-
1.14) 
5.87(5.32-
6.49) 
1.31(1.14-
1.50) 
1.06(0.87-
1.30) 
1.23(1.14-
1.32) 
1.02(1.02-
1.02) 7.4E-16 0.13 6.94E-266 0.0001 0.56 4.13E-08 3.48E-28 
rs8034191_15q
25 
Usual-
Func 
1.03(0.85-
1.23) 
0.98(0.76-
1.26) 
5.23(4.31-
6.40) 
1.27(1.05-
1.54) 
1.07(0.82-
1.40) 
1.29(1.19-
1.41) 
1.02(1.02-
1.03) 0.7671 0.89 2.01E-60 0.0165 0.60 2.43E-09 2.19E-33 
NOIA-
Stat 
1.26(1.19-
1.33) 
1.04(0.96-
1.13) 
5.09(4.48-
5.80) 
1.29(1.08-
1.55) 
1.07(0.82-
1.40) 
1.29(1.19-
1.41) 
1.02(1.02-
1.03) 2.23E-15 0.35 2.10E-136 0.0055 0.60 2.43E-09 2.19E-33 
a. The study group has been used as covariates. Add=Additive effect; Dom=Dominant effect; SM=smoking. 
b. Func=The usual functional model; NOIA-Stat=The NOIA statistical model. 
 
  
53 
 
 
 
 
Table 3.5 Analyses after stratification by smoking status for rs16969968 and rs8034191 in 
15q25 a 
 
 
Non-smokers Smokers 
SNPs Add Sex Age Add Sex Age 
OR (95% CI) b 
rs16969968 1.00(0.88-1.13) 1.41(1.17-1.70) 1.00(1.00-1.01) 1.31(1.24-1.38) 1.19(1.09-1.29) 1.02(1.02-1.03) 
rs8034191 1.02(0.86-1.22) 1.95(1.52-2.52) 1.02(1.01-1.03) 1.32(1.25-1.40) 1.21(1.11-1.33) 1.02(1.02-1.03) 
P-value 
rs16969968 0.95 0.0003 0.42 2.08E-23 3.29E-05 1.41E-30 
rs8034191 0.81 2.05E-07 0.003 2.50E-21 2.78E-05 2.90E-29 
a The study group has been used as covariates. Add=Additive effect. 
b OR=Odds Ratio; CI=Confidence Interval 
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3.3 Discussion 
      In this chapter, we described a new extension of the existing NOIA framework which was 
originally developed for testing GxG interactions for quantitative traits. We extended it to include a 
binary environment trait and explored the testing of GxE interactions along with the main effects. 
The NOIA model was also extended to case-control analyses, although some of the important 
properties of the NOIA model did not hold true. One is that estimates of the parameters from logistic 
regression for the case-control trait are no longer statistically uncorrelated under the alternative 
model that there is an association. Also, the estimates of the parameters from logistic regression of 
the full NOIA model are not consistent with those from the reduced (additive) NOIA model. We also 
showed the evidence of the second point by the real data analyses by comparing the results in Table 
3.1 and Table 3.3.  
       By simulation studies, we stated that NOIA statistical models were usually more powerful than 
the functional models for detecting main effects and interaction effects for both quantitative traits 
and binary traits. This point is consistent with the results from real data analyses. When we 
performed additive models without interaction effect testing integrated, the NOIA-Stat model 
showed same performance with the Usual-Func model (Table 3.1). After the interaction effect was 
tested along with the additive effect, the NOIA-Stat preserved the power for identifying the additive 
effects whereas the Usual-Func did not (Table 3.2). When we performed full models without 
interaction effect testing integrated, the NOIA-Stat model presented similar performance with the 
Usual-Func model (Table 3.3). Similarly, after the interaction effect was tested along with the main 
effects, the NOIA-Stat model preserved the power for identifying the main genetic effects, whereas 
the Usual-Func model had greatly larger P values compared with those tested without interaction 
effects incorporated (Table 3.4).     
      The application of the NOIA-Stat model confirmed four SNPs in 5p15 and 15q25 region to be 
significantly associated with lung cancer susceptibility in Caucasians population: rs2736100, 
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rs402710, rs16969968 and rs8034191. The full Usual-Func model failed to identify them or with 
larger P values. We also validated that rs16969968 and rs8034191 in 15q25 region are significantly 
interacted with smoking in Caucasians population by stratification analyses. Potential interactions of 
SNP rs2256543 on 6p21 with smoking on contributing to lung cancer risk are indicated in our study 
which is the first report. It is interesting that no main effects were found for this SNP, however 
which happens in reality [60]. Such cases that display interaction but no marginal effect are usually 
ignored in usual one-locus analyses. However, this interaction needs more evidence to be validated.       
      Comparing the performance of the NOIA statistical model and usual functional model, we can 
clearly state the preference of the NOIA model on modeling GxE interactions for both quantitative 
traits and qualitative traits. Even for one-locus genetic analysis, such as GWAS, one should consider 
applying the statistical model, since it orthogonalizes the additive and dominant effects and hence 
improves power of detecting genetic effects. 
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CHAPTER 4 
The NOIA Model Integrating Parent-of-Origin Effects (POEs) for Association 
Study of QTLs and Complex Diseases 
 
      In this chapter, we propose to implement the NOIA framework by incorporating POEs. The 
highly significant genetic markers identified via GWAS have explained only a proportion of the 
heritability of most human diseases [13, 61]. Genetic imprinting affects expression of genes and may 
explain some of the missing heritability. Both the orthogonal NOIA statistical model and usual 
functional model ignored the important genetic phenomenon, imprinting effects. We propose that 
more disease-associated genes could be detected by incorporating POEs with orthogonal models than 
by using traditional models, and that the NOIA POE model would fulfill the requirement of 
maintaining the power to detect the main allelic effect for complex diseases when multiple loci 
contribute to disease risk. The orthogonality of the statistical formulation of NOIA framework is 
important, especially when multiple loci are contributing to the outcome. We also proposed that 
using Kroneker product rule, our one-locus NOIA POE formulation can be easily extended to the 
general case of multiple loci (and environmental factors) to model general GxG/GxE interactions in 
the presence of imprinting effect, making NOIA a unified framework for detecting GxG/GxE 
interactions along with imprinting effects. Here we focus on one-locus association analysis for 
quantitative trait, implementing NOIA into a POE integrated framework by re-parameterization.  
      From the NOIA statistical model without POE (Stat-Usual, equation (5)) and the traditional 
functional model without POE (Func-Usual, equation (3)), we derived the formulas of several 
different quantitative trait association models, including a statistical POE (Stat-POE) model and a 
functional POE (Func-POE) model. Then, we evaluated the performance of the Stat-POE and Func-
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POE models. We also compared the performance of the POE models (Stat-POE and Func-POE) with 
that of the models without POE incorporated (Stat-Usual and Func-Usual). These studies were all 
performed for both a simulated quantitative trait dataset and a qualitative trait dataset. We found that 
the incorporation of POE into the statistical model did not affect the estimation of the main allelic 
effect. Although our methods are currently developed and evaluated for single locus association 
study, they can be readily extended to gene-gene interaction or gene-environment interaction models.  
      In following sections, considering the orthogonal property of the NOIA statistical model and the 
non-orthogonal functional model mentioned in Chapter 1, we introduce our methodology extension 
of these two models by integrating POE detection. We also sought to evaluate the performance of 
these extended models in detecting both the overall genetic effect and POEs. 
 
4.1 Methodology Development of the POE Models 
      Instead of three genotypic values in usual models without POE incorporation, the vector of 
genotypic values G has four components: G, G, Gand G, in which the first allele represented 
by the first digit in the subscript is transmitted from the mother, and the second allele from the father. 
We used N and N to denote the number of maternal and paternal reference allele A, respectively. N1 and N2 are independent variables with binomial distributions, respectively. 
That is, 
N   0    if G  G or G1    if G  G or G ¡ ,                                                (17a) 
N   0    if G  G or G1    if G  G or G ¡.                                                 (17b) 
      Similar to equation (1), the vector of the observed phenotypes G can be expressed as G  Z · G 
and 
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$GG%%G &'
( 
"
###
#$
1 0% %0 1% %
0 0% %0 0% %0 0% %0 0% %
1 0% %0 1% % &
'''
'( · 1GGGG3, 
where the new n rows of matrix Z represents the corresponding genotype for each individual.  
      First, we extended the usual functional (Func-Usual, equation (3)) and statistical model (Stat-
Usual, equation (5)) by decomposing the additive effects into paternal and maternal additive effects 
(see Appendix 3.1). In the process of extension of the statistical model, our motivation was to 
incorporate POE detection while still maintaining its orthogonality. Next, these models were 
transformed into an equivalent but more comprehensive framework, which was straightforward for 
detecting the main allelic additive effect and POE simultaneously. The main allelic effects denote the 
overall additive effect on the outcome trait conferred by this allele, and the POE is defined as the 
imprinting effect of the allele with paternal origin over the same allele with maternal origin. The 
following subsections depict the developed models, and Appendix 3.1 shows the details about how 
we derived these new models. 
4.1.1 The POE Functional (Func-POE) Model  
      First, we defined r and r as the main allelic additive effect and POE of the locus, or gene, 
respectively. Then, we extended the functional model (3) to the following, 
G  R  FWfF` r  F`FW r  εd,                                                (18) 
which could be also expressed as 
1GGGG3  S.`E.`  "#
$1 01  0 0 11 1 1 2  10 0&'
( 5 Rrrd ;.                                    (19) 
The inverse is  
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E.`  5 Rrrd ;  S.`
G  1 1 021 0 0 00 10 12   21 0 2 3 1
GGGG3.                         (20) 
4.1.2 The POE Statistical (Stat-POE) Model 
      Here we let γ and γ denote the main allelic additive effect and POE of the locus, or gene, 
respectively. Similarly, we extended the orthogonal statistical model (5) to following. 
G  μ  FWfF`CF7WfF7`D γ  F`FWCF7 `F7 WD γ  εδ,                            (21) 
where N7and N7 denote the means of Nand N, respectively, whereas Vand  V denote the variance 
of Nand N, respectively. In the models without POE incorporated (Func-Usual and Stat-Usual), p relates to the probability of an allele that has an allele A1 from either parent. In our new models, 
the meaning of p is different since it relates to the probability of an allele that has allele A1 from 
the mother and allele A2 from the father. p denotes the probability of an allele that has allele A2 
from the mother and allele A1 from the father. Thus,  
N7  p  p, N7  p  p, V  Cp  pDCp  pD  N7C1 2 N7D, V  Cp  pDCp  pD  N7C1 2 N7D. 
      Therefore, according to equation (21), the vector of genotypic values can be expressed as 
1GGGG3  S4`E4`  "
###
$ 1 CF7 WfF7`D1 CF7WfF7 `D
CF7`F7WD     εCF7`F7WD     ε    1 CF7WfF7`D    1 1 2 F7 WfF7 `
CF7`F7 WD εCF7`F7WD ε &
'''
( 5 μγγδ ;,                   (22) 
where  
ε  5εεεε;  1
22ppp/D2ppp/D2ppp/D22ppp/D3,                                       (23) 
  
60 
 
and 
D  ppp  ppp  ppp  ppp.                         (24) 
      The inverse is then E4`  S4` G which can be expressed as 
5 μγγδ ;  "#
$ p ppEE pE pEE pE p ppEE pE   pEE pE  pEE 2pE  pEE 2pE   2   p
EE 2pE pEE 2pE 2  &'
( 1GGGG3,                (25) 
If we define 
¢pAE  C21DFWCGHDpAC1 2 N7DF`CGHDCN7DF`CGHD 2 pAN7F`CGHDC1 2 N7DF`CGHD/DpAEE  C21DF`CGHDpAC1 2 N7DFWCGHDCN7DFWCGHD 2 pAN7FWCGHDC1 2 N7DFWCGHD/D¡,      (26) 
where NCAD and NCAD denoted Nand N value of the genotype AA, respectively. From equations 
(25) and (26), each column of S4`  is independent of the others therefore the parameters are 
orthogonal. 
       S4`  can also be expressed as  
"
##$
p p2 bWWCbW`F7Wfb`WF7`D£ bW`JbWWF7Wb``CF7`DK£
p p2 b`WCb``CF7WDbWWF7 `D£  b``Jb`WCF7WDfbW`CF7`DK£   2 bWWCbW`F7Wb`WF7`D£   bW`JbWWF7Wfb``CF7`DK£   2  
2 b`WCb``CF7WDfbWWF7`D£ b``Jb`WCF7WDbW`CF7`DK£ 2  &
''(.     (27) 
      The POE functional model (Func-POE) and statistical model (Stat-POE) are related by 
5 μγγδ ;  "#
$1 FWfF`0 1
F`FW p  p0 pEE  pEE  pE  pE0 00 0 1 pEE  pEE 2 CpE  pE D0 1 &'
( 5 Rrrd ;,                       (28) 
where 
pEE  pEE 2 CpE  pE D  2ppCp 2 pD/D, 
which means γ  r for the case of equal frequency of the two types of heterozygote (p  p). 
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4.2 Results 
4.2.1 Orthogonality of the Stat-POE Model 
      We have previously showed that the Stat-Usual model was orthogonal in the sense that the 
estimates of the four parameters were uncorrelated [22]. As stated in the previous section, from 
equations (25) and (26), the lack of correlation of the column values of S4` implies that the Stat-
POE model is also orthogonal. The fact that the variance of G can be decomposed into two 
independent additive components and one dominance component also reflect the orthogonality of the 
statistical imprinting model. To prove the orthogonality, we performed the following decomposition. 
From Equation (21), we have 
V  Var ¤N  N 2 CN7  N7D2 γ¥  Var ¤N 2 N 2 CN7 2 N7D2 γ¥  VarCεδD 
                               2Cov §FWfF`CF7WfF7`D γ, F`FWCF7`F7WD γ¨.                                                  (29) 
Note that 
Cov §FWfF`CF7 WfF7`D γ, εδ¨  γδCov gFWfF` , εh  0, 
and similarly,  
Cov §F`FWCF7 `F7WD γ, εδ¨  0. 
      Also, VarCεδD  δvarCεD  4ppppδ/D. Therefore, we can express the additive and 
dominant variance components as 
V©  γVar gFWfF` h  γVar gF`FW h  2γγCov gFWfF` , F`FW h,             (30) Vª  4ppppδ/D.                                            (31) 
     To show that the additive variance, V©, can be decomposed to be two parts that are dependent on 
only two additive effects (γand γ) respectively, Cov gFWfF` , F`FW h  0 needs to be satisfied. 
And, as we know 
Cov cN  N2 , N 2 N2 d  14  EJCN  NDCN 2 NDK 2 14 ECN  NDECN 2 ND 
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 14 V 2 14 V  14 Cp  pDCp  pD 2 14 Cp  pDCp  pD 
 
 Cp 2 pDCp 2 pD,                                                                                                             (32) 
which is indeed equal to 0 under the condition that p  p or p  p. In this way, we divided 
the additive variance component into two independent parts as follows:  
V  Cp  pDCp  pD  N7C1 2 N7D, V  Cp  pDCp  pD  N7C1 2 N7D, 
V©W  ©W`
 VarCN  ND  ©W`
 JCp  pDCp  pD  Cp  pDCp  pDK,     (33) 
V©`  ©``
 VarCN 2 ND  ©``
 Cp 2 pDCp 2 pD.                          (34) 
And V  V©W  V©`  Vª. 
      The two additive variance components V©W and V©`  are related only to the additive effects 
parameters γand γ, respectively, one due to overall genetic effect and the other due to POEs. The 
dominance variance component  Vª is only related to the dominance effect δ. Of the fact that the 
variance components can be decomposed into two independent additive components and one 
dominant component suggests the notion that the transformed POE statistical model is orthogonal. 
We also proved that the Stat-POE model is orthogonal before transformation (Appendix 3.2). On the 
other hand, by checking whether X · X is a diagonal matrix, we showed that the transformed Stat-
POE model was orthogonal (Appendix 3.3).  However, for the transformed Func-POE model, the 
variance components could not be decomposed into three independent parts, indicating that the 
Func-POE model is not completely orthogonal (Appendix 3.4). 
4.2.2 Simulation Methods 
      We performed simulation analysis for both quantitative traits and qualitative traits (case-control) 
using an approach similar to that used in [22], and the simulated data were analyzed using the four 
aforementioned models: Stat-POE, Func-POE, Stat-Usual and Func-Usual. We already derived the 
test statistics of the Stat-Usual and Func-Usual in Appendix 2.2. Similarly, the Wald test statistic for 
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the Stat-POE model is 
√_`£
"
###
$ √D √DCF7WfF7`DebW`fb`W JCF7 WfF7`DKebW`fb`W
√D √DJCF7 WfF7 `DKebW`fb`W JCF7WfF7 `DKebW`fb`W0 eCF7 WfF7`D`fCF7 WfF7`Dfb``2abW`b`Wb``bWW abWWb`Wb``bW`
2 eCF7 WfF7 `D`fCF7 WfF7 `Dfb`` 0abWWbW`b``b`W 2abWWbW`b`Wb`` &
'''
( ·
ZE · y with the second to fourth rows for the main additive effect, POE and dominant effect testing, 
respectively. Since the functional model is not orthogonal (Appendix S3.4), it is difficult to obtain an 
expression for the test statistic of the Func-POE model. 
4.2.2.1 Simulation of Data with a Quantitative Trait 
      To simulate samples of independent individuals with a quantitative trait controlled by a diallelic 
locus, we assumed that the gene is under HWE. The case that a gene is not under HWE will be 
investigated in our future work. For a given value of the minor allelic frequency (p) in the 
population, genotype 11, 12, 21, 22 were assigned to an individual with probabilities C1 2 pD, 
pC1 2 pD, pC1 2 pD and p respectively. We assumed the genotype frequencies of the two types of 
heterozygotes were the same in the population. We also assumed the phenotype was influenced by a 
main allelic additive effect, a POE, and a dominant effect. From a prespecified vector of parameters ( 
E.  R, a, a, d ), we assigned each individual a genotypic value according to his/her assigned 
genotypes. Then, by randomly generating a value from a normal distributions with prespecified mean 
and variance (0 and σS ), we generated an observed phenotype/trait by adding this residual to the 
previously assigned phenotypic value. We used data from 2000 individuals as a replicate and 
simulated 1000 replicates for each genetic model. 
      In the simulation study of a quantitative trait, three scenarios were simulated with different levels 
of POE (Table 4.1). The minor allele frequency p was set to 0.28, and the residual variance σS was 
144.0. The true values of the four parameters in these three scenarios are shown in Table 4.1. For the 
sample size with 2000 individuals, the computation speeds of the four models on quantitative traits 
  
64 
 
analysis are: 22 seconds for the Stat-POE model, the Stat-Usual model and Func-Usual model, 
respectively; 24 seconds for the Func-POE model. 
4.2.2.2 Simulation of Data with a Qualitative Trait 
      Ma et al. [22] previously derived the formulation of the statistical model without POE 
incorporated in quantitative traits and demonstrated that a similar statistical model could also be 
defined for a qualitative trait by handling the genetic effects as the logit function of the disease. As 
mentioned in previous sections, the orthogonality of that model does not exist for the qualitative trait 
under the alternate hypothesis when there is a genetic effect, but is valid under the null hypothesis of 
no effect. It is not difficult to show that it is still the case for our Stat-POE model. Here we 
performed simulations to evaluate the performance of our POE-related models in a case-control 
study design. 
         Briefly, we used the logistic model and Bayes’ theorem to set the genotype of each individual 
according to the prespecified genetic effect terms, E.  R, a , a, d . The disease penetrance for 
each genotype was determined by 
PrCd  1|ijD  fSbJGHK,  
where d denotes the disease status with value 1 for patients and 0 for control. GA was the genotypic 
value when the genotype was ij with ij  11,12,21 or 22. Then the distributions of the four 
genotypes in the cases was determined by 
PrCij|d  1D  GH/gfSbJGHKh∑ «¬/JfSbC«¬DK«¬  .  
      As in the simulation study for a quantitative trait, PA is the genotype frequency of 11, 12, 21 and 
22 in the population, determined by C1 2 pD, pC1 2 pD, pC1 2 pD and p, respectively. For 
simulating controls in the population, we used a similar distribution as follows 
PrCij|d  0D  GH/gfSbJGHKh∑ «¬/JfSbC«¬DK«¬  .  
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      For each replicate, 1000 cases and 1000 controls were generated, and a total of 1000 replicates 
were simulated. The minor allele frequency p was set to 0.28. Two scenarios were simulated with 
different levels of POE (Table 4. 1). The simulating values of the parameters in the two different 
scenarios are shown in Table 4.1. 
Table 4.1 Simulation true values of genetic effects for quantitative and qualitative traits datasets. ­ 
denotes intercept; ® and ® denote overall genetic effect and POE effect, respectively; and ¯ denotes 
dominant effect. Three scenarios with strong, medium and weak POEs were simulated for 
quantitative traits; two scenarios with strong and weak POEs were simulated for qualitative traits. 
 
 ­ ® ® ¯ 
Quantitative trait 
Scenario 1 90.0 3.0 -3.0 1.2 
Scenario 2 90.0 3.0 -2.0 1.2 
Scenario 3 90.0 3.0 -1.0 1.2 
Qualitative trait 
Scenario 1 100.0 2.0 -2.0 0.5 
Scenario 2 100.0 2.0 -0.6 0.5 
 
      To determine whether the setting of the MAF value influence the performance of the models, we 
also simulated two additional scenarios with different MAF values (0.03 and 0.48) for both 
quantitative traits and qualitative traits. 
4.2.3 Results for simulated data 
      First we performed a simulation study for a quantitative trait in three scenarios with strong, 
moderate, and weak imprinting effect while the main allelic additive effect remained the same (Table 
4.1). The true values of the four parameters in these three scenarios are shown in Table 4.1. The 
density distributions of all four effects after analyzing 1000 replicates in scenario 1 with strong 
imprinting effect is shown in Figure 4.1. The estimates of all four parameters were accurate for both 
the Stat-POE and Func-POE models. Compared with the Func-POE model, the Stat-POE model had 
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smaller variance in most cases for detecting the intercept and main allelic additive effect terms. The 
estimates for the POE term and dominant effect term were the same between the Func-POE and Stat-
POE models. Similar patterns could be detected for the other two scenarios (data not shown).  
 
 
Figure 4.1 Density distributions of the estimates of the parameters from a simulated data analysis 
with a quantitative trait influenced by a genetic factor and by strong POE (Scenario 1). The pre-
specified minor allele frequency was 0.28. The values of the four parameters were E. 90.0, 3.0, 23.0, 1.2  and  E4  91.3, 4.05, 23, 1.2  for the functional POE (Func-POE) model 
and the statistical POE (Stat-POE) model, respectively. The solid arrows denote the true simulated 
values of the parameters for Stat-POE model and the dashed arrows denote those for the Func-POE 
model. 
 
      To evaluate the performance of these models in detecting a main allelic additive effect and POE, 
we calculated the statistical power of four models under different critical values of P values obtained 
using a Wald test (Fig. 4.2). Figure 4.2 shows the power for detecting the main allelic additive effect 
for scenario 1 with strong POE. The power of both statistical models (Stat-POE and Stat-Usual) for 
detecting additive effects was greater than that of both functional models (Func-POE and Func-
Usual). The power of detecting additive effect was the same for the Stat-POE and Stat-Usual models. 
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It was also the same for the Func-POE and Func-Usual models. In the other two scenarios in which 
medium or weak POE was simulated, identical results(data not shown) were obtained for the main 
genetic effect term as shown in Figure 4.2a, since the main allelic additive effect was set to the same 
value, 3.0 (Table 4.1). These results indicated that the power for detecting the main allelic effect did 
not change even if a POE parameter was integrated into the analysis model. The performance of 
these four models for detecting dominant effects was the same in three scenarios (data not shown), 
which was consistent with the formulations.
 
Figure 4.2 Power under different critical values of the P values obtained using the Wald test for the 
quantitative simulation data shown in Table 4.1. (a) Power for detecting the main allelic additive 
effect in scenario 1 when strong POE exists. Power for detecting POE of the Stat-POE and Func-
POE models was compared for scenario 1 (b), scenario 2 (c), and scenario 3 (d). 
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      Figure 4.2b-d shows the power of the Stat-POE and Func-POE models for detecting the POE in 
three scenarios. The performance of the two POE models remained the same for the three scenarios. 
This is because in our simulation, the genotype frequency values for the two types of heterozygotes 
were set at the same value which is valid when HWE hold true. This results in pEE  pEE 2 CpE 
pE D  bWWb``CbW`b`WD£  0. Therefore, according to equation (28), the POE repressor in the Stat-
POE model was equivalent to that in the Func-POE model. When the assumption that the genotype 
frequencies for the two heterozygotes are the same is violated, it will result in different performance 
of the Stat-POE and Func-POE models for detecting POE. Additionally, the overall power decreases 
when the POE decreases (Fig. 4.2b-d). 
      To evaluate whether the MAF influences the estimation of the genetic effects by these models, 
we also performed analyses for quantitative traits when the MAF was 0.03 and 0.48, respectively 
(Fig. S4.1-S4.2). Figure S1 shows that when strong POE existed, the Stat-POE model still presented 
extremely greater power than the Func-POE model in detecting main additive effect for rare variants 
(MAF=0.03). Figure S4.2 shows that when strong POE existed, the Stat-POE model presented 
slightly greater power than the Func-POE model in detecting main additive effect for variants with 
MAF as 0.48. 
      Similarly, we also performed analyses for simulated case-control data. The simulating values for 
each of the two scenarios are shown in Table 4.1. Figure 4.3 shows the density distributions of all 
four effects after analyzing 1000 replicates in scenario 1. Similar patterns were detected for the 
distributions of the four parameters as in the quantitative trait. And the estimates were all accurate 
for both the Stat-POE and Func-POE models, except for the intercept term. The differential 
estimation of the intercept term arose from non-random sampling in our simulation. The variance of 
the main allelic additive effect was still smaller via analysis using the Stat-POE model than via 
analysis using the Func-POE model. And the estimate distributions are very close or the same for 
these two models for detecting POE and dominant effect. 
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      Figure 4.3 Density distributions of the estimates of all four parameters from a simulated data 
analysis with a qualitative trait influenced by a genetic factor and by strong POE. The pre-specified 
minor allele frequency was 0.28; the true values of the four parameters were E.  100.0,2.0, 22.0,0.5  and  E4  100.0,2.44, 22,0.5  for the Func-POE and the Stat-POE 
models, respectively. The solid arrows denote the true simulated values of the parameters for Stat-
POE model and the dashed arrows denote those for the Func-POE model. 
 
      Figure 4.4 shows the power of the four models for detecting the main allelic additive effect, POE 
and dominant effect when the trait was affected by relatively strong POE for case-control data. The 
performance of the Stat-POE model was slightly better than that of the Stat-Usual model, and the 
performance of both was better than that of the functional models, Func-POE and Func-Usual (Fig. 
4.4a). The Stat-POE and Func-POE models had the same power for detecting POE (Fig. 4.4b, 4.4c). 
Interestingly, both POE models (Stat-POE and Func-POE) had higher power for detecting 
dominance effect than the usual models, Stat-Usual and Func-Usual (Fig. 4.4c).  
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Figure 4.4 Power under different critical values of the P values obtained using the Wald test for the 
case-control simulation data influenced by a genetic factor with strong POE (scenario 1). The minor 
allele frequency was 0.28.   
 
      Another simulation was performed with a moderate POE for case-control data (Table 4.1, 
scenario 2; Fig. 4.5). Interestingly, the performance of the Stat-POE model was not much better than 
that of the Stat-Usual model (Fig. 4.5a) for detecting the main allelic additive effect (Fig. 4.4a). For 
detecting the main allelic additive effects, the statistical models (Stat-POE and Stat-Usual) had much 
higher power than the functional models, Func-POE and Func-Usual. The statistical models and 
functional models had the same or very close power with and without the incorporation of POE, 
respectively. The Stat-POE and Func-POE models had the same or very close power for detecting 
POE and dominant effect (Fig. 4.5b, 4.5c). 
      Simulations were also performed when MAF was set as 0.03 and 0.48 for case-control traits, 
respectively (Fig. S4.3-S4.4). For rare variants (MAF=0.03), the Stat-POE model presented 
extremely greater power than the Func-POE model in detecting main additive effect, although 
slightly greater power was observed for Func-POE model in detecting the POE (Fig. S4.3). For 
variants with MAF=0.48, the Stat-POE model presents extremely greater power than the Func-POE 
model in detecting main additive effect and dominant effect (Fig. S4.4). The power of the Stat-POE 
model was even higher than that of the Stat-Usual model in detecting the main additive effect (Fig. 
S4.4a). 
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      Figure 4.5 Power under different critical values of the P values obtained using the Wald 
test for the case-control simulation data influence by a genetic factor with moderate POE 
(scenario 2). The minor allele frequency was 0.28. 
 
      Type I error was also inspected for both the quantitative trait and the qualitative trait by 
simulating a null scenario where there was no main genetic effect or POE. We estimated the type I 
error for the main additive effect, POE and dominant effect for both quantitative traits and case-
control traits when the MAF was set as 0.03, 0.28 or 0.48 (Table 4.2). The false positive rate for 
detecting the additive effect was almost the same for the statistical and functional POE models in 
most scenarios we simulated (around 0.05 or less for the 1000 replicates). The false positive rate for 
detecting the additive effect was smaller estimated from the Func-POE model than that from the 
Stat-POE model, when MAF was set as 0.03 for case-control traits. For detecting POE, these two 
models usually had very close false positive rates for both quantitative and case-control traits. 
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Table 4.2 Type I error for simulation of quantitative and case-control traits data sets. False positive 
rates for the genetic effects estimated from the Stat-POE, Func-POE, Stat-Usual and Func-Usual 
models under different minor allele frequency settings. Add= overall genetic additive effect; 
Dom=dominant effect; MAF=minor allele frequency.  
 
MAF=0.03 MAF=0.28 MAF=0.48 
Models/MAF vww POE Dom vww POE Dom vww POE Dom 
      Quantitative trait 
Stat-POE 0.047 0.037 0.059 0.055 0.038 0.048 0.053 0.043 0.043 
Func-POE 0.055 0.036 0.059 0.056 0.037 0.048 0.052 0.042 0.043 
Stat-Usual 0.048   0.06 0.056   0.048 0.053   0.044 
Func-Usual 0.048   0.06 0.056   0.048 0.053   0.044 
      Case-control trait 
Stat-POE 0.044 0.062 0.017 0.05 0.045 0.046 0.047 0.049 0.039 
Func-POE 0.01 0.063 0.017 0.049 0.047 0.046 0.049 0.048 0.039 
Stat-Usual 0.045   0.017 0.047   0.047 0.047   0.038 
Func-Usual 0.045   0.017 0.047   0.047 0.047   0.038 
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Table 4.3 Summary of the power of the Stat-POE and Func-POE models in different simulation 
scenarios for both quantitative traits and case-control traits. Add: overall genetic additive effect; 
Dom=dominant effect.  Threshold of the P value was 0.001. 
 
MAF=0.03 MAF=0.28 MAF=0.48 
 
Strong 
POE 
Weak 
POE 
Strong 
POE 
Weak 
POE 
Strong 
POE 
Weak 
POE 
  Quantitative traits 
Add Stat-POE 0.98 0.98 0.93 0.94 0.79 0.78 Func-POE 0.01 0.01 0.36 0.35 0.75 0.75 
POE Stat-POE 0.4 0.1 0.61 0.1 0.77 0.03 Func-POE 0.4 0.1 0.61 0.1 0.77 0.02 
Dom Stat-POE 0.005 0.007 0.07 0.06 0.12 0.15 Func-POE 0.005 0.007 0.07 0.06 0.12 0.15 
  Case-Control traits 
Add Stat-POE 0.73 0.73 1 1 1 1 Func-POE 0.001 0.001 1 1 1 1 
POE Stat-POE 0.8 0.33 1 0.33 1 0.61 Func-POE 1 0.41 1 0.38 1 0.73 
Dom Stat-POE 0.04 0.05 0.29 0.35 0.8 0.9 Func-POE 0.04 0.05 0.29 0.35 0.8 0.9 
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4.3 Discussion 
      In this chapter, we extended the NOIA framework, which was initially developed for epistasis 
quantitative traits analyses by incorporating POE for genetic association analysis. Herein, we 
propose a unified framework for one-locus association study that allows for both main allelic 
additive effect and POE estimation via linear regression. By simulation study, we illustrated the 
statistical properties of this implemented framework on one-locus association study. We summarized 
the detailed comparison of the performance of the Stat-POE and Func-POE models in Table 4.3. In 
most scenarios we simulated, the Stat-POE model had greater power than the Func-POE model in 
detecting the main additive effect. For testing imprinting effect, the Stat-POE model had same power 
as the Func-POE model for quantitative traits whereas the former presented slightly worse power 
than the latter for qualitative traits.  
      We used genetic variance decomposition to show that the Stat-POE model was orthogonal when 
either HWE or equal minor and major allele frequencies is satisfied for quantitative traits (equations 
29-33). Thus, even when the POE was absent, estimating of the main allelic additive effect was not 
affected when a new parameter was added in the analytic model. This was not true for the Func-POE 
model, as demonstrated by simulation results for quantitative traits (Fig. 4.2a).  Although the Func-
POE model was not orthogonal (Appendix 3.4), the same performance of the Func-POE and Func-
Usual models for detecting the main allelic additive effect in Figure 4.2a could still held true as the 
power between these two models was only slightly different. Another reason might be because the 
term °W± CovCN  N, εD in equation (D3) (Appendix 3.4) is rather small. The Stat-POE and Func-
POE models we proposed could also be applied to qualitative traits via logistic regression although 
the property of orthogonality would no longer exist under the alternative model [22]. When 
orthogonality exists under the null, the subsequent tests have appropriate type I error rates, but the 
failure of orthogonality under the alternate model can lead to improper estimates of heritability, 
although the estimators may be less biased than those that are obtained from the functional models. 
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      Using simulations, we demonstrated that the statistical models, including the Stat-POE and Stat-
Usual models, had better performance for detecting the main allelic additive effect than the 
functional models, Func-POE model and Func-Usual for both quantitative traits and qualitative 
traits. And the same power of these two POE models on detecting the POE arose when p  p 
was true. Stat-POE model had better performance on detecting the main allelic additive effect than 
the Stat-Usual model for qualitative traits when strong POE exists. The power was the same for 
detecting the main allelic effect even if a POE parameter was integrated into the analysis model and 
supported orthogonality of the Stat-POE model (Fig. 4.2a, Fig. S4.1 and S4.2). The performance of 
our framework was not exactly the same in quantitative and qualitative trait simulation studies. The 
simulation study for both quantitative and qualitative traits showed that the estimates of all four 
parameters were accurate for both the Func-POE and Stat-POE models. However, the performance 
of these two models for detecting the main allelic effect and dominance effect presented a different 
pattern in qualitative traits (Fig. 4.4 and 4.5). In qualitative traits, for detecting the main allelic effect, 
the statistical (Stat-POE and Stat-Usual) models, still had greater power than did the functional (Stat-
Usual and Func-Usual) models in most cases, regardless of the strength of the POE, which is 
consistent with the findings of the quantitative traits simulation study (Fig. 4.2). However, the power 
of the Stat-POE and Stat-Usual models was not usually the same for the qualitative trait simulation 
in different scenarios (Fig. 4.4a, 4.5a), which varied from the findings of the quantitative traits 
simulation (Fig. 4.2). The performance of the four models on detecting the dominance effect is also 
different in the  simulation analysis for a qualitative trait (Fig. 4.4c; Fig. S4.3 and S4.4), which 
shows that the POE models (including the Stat-POE and Func-POE) usually have greater power than 
the usual models. This difference in performance arises because the test statistics used for logistic 
and linear regression differ. 
      We can also illustrate the reason why the proposed model could detect more disease-associated 
genes than the traditional models in model setting as follows. First, the orthogonal (Stat-Usual) 
model proposed by Alvarez-Castro et al. has an advantage of orthogonalizing the estimating of the 
  
76 
 
additive effect and dominant effect but the usual model (Func-Usual) does not. We constructed the 
test statistic of the Stat-Usual and Func-Usual models for quantitative traits with dominance 
component and without dominance effect (Section 1.4 and Appendix 2.2). The test statistic for 
estimating the additive effect did not change if the dominance component was removed for the Stat-
Usual model. However, the test statistic was not consistent if the dominance component was 
removed from the Func-Usual model. Thus, the Stat-Usual model is preferred than the Func-Usual 
model in association studies when dominance component is incorporated. Second, we also compared 
the test statistic of the Stat-Usual and our newly developed Stat-POE models. We found that the test 
statistic of the main additive effect was the same for the two models, which was consistent with the 
simulation studies. And even in simulation studies for a case-control trait, we found that the Stat-
POE had greater power for detecting the main additive effect than the usual orthogonal model (Stat-
Usual). Comparing the test statistic of the Func-POE and Fun-Usual models, we found that the 
estimation of the main genetic effect was not consistent, and the power decreased when POE testing 
was included. Therefore, Stat-POE model could detect more significant additive effect signals than 
the Func-POE model. 
      Several recent studies have incorporated POEs in association analyses for quantitative traits. 
Genome-wide rapid association using mixed model and regression (GRAMMAR) and its extension 
are a recently developed approach that is based on a measured genotype approach and has been 
shown to have greater power than the transmission disequilibrium test (TDT)-based tests [62]. A 
maximum likelihood test was also developed for detecting POEs using haplotypes [63]. Ainsworth et 
al. also described an implementation of a family-based multinomial modeling approach that allows 
for imprinting detection [52]. This method used family data, case-mother duos or case-parents trios, 
to look for departures in observed genotypes distributions from expected distributions among 
affected offspring, given the genotypes of their parents. The mechanism of this approach is still more 
related to the TDT test. However, to our knowledge, our approach is the only one that has the 
advantage of orthogonality on the effects estimation for association studies of detecting POE. NOIA 
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was previously proposed and formularized for gene-gene interaction analysis models of quantitative 
traits and was further implemented and extended by Ma et al. [22] to r reduced genetic models and 
estimating effects from both genetic and binary environmental exposure. However, neither of these 
models had the potential to detect POE. We already found that when POE was not incorporated, the 
power of the statistical model (Stat-Usual) was greater than that of the functional model (Func-
Usual) in most cases. This finding held true in our study for detecting main effects even when POE 
was integrated. Our study exemplifies another significant implementation of NOIA that adopts the 
orthogonal property of the statistical model if the family data are available or if phasing is plausible 
for obtaining the parental transmitting status of the candidate disease-associated locus. Because 
alleles of different parental origins can exert different effects, the effect contributing to the disease 
outcome may be masked in usual models that can detect only the main allelic additive effect. The 
methodology and simulation study used for our extension of NOIA yielded a plausible means of 
detecting more genes that contribute to complex diseases or quantitative traits that were not detected 
in routine GWASs.  
      Although our extension significantly contributes to disease gene mapping, pedigree data are 
needed for our framework to be used to estimate transmitting information of each heterozygotes or 
homozygotes locus. Obtaining the transmitting status of one locus is more difficult for non-
informative pedigrees than for informative pedigrees which need to be determined by nearby linked 
loci or haplotype phasing. This limits the application of our model in GWAS. However, with the 
development of genotyping technique, it will be possible to obtain pedigree data with sufficient 
sample size in the near future. Another direction of our next step will be generalizing our formulation 
to the case of non-deterministic genotypes, e.g. with probabilistic parental information or missing 
data, to incorporate the phasing uncertainty of genotypes. 
      The motivation of our implemented framework was based on the orthogonality property of NOIA 
which allows model selection and variance component analysis more straightforward. A next step is 
to extend the formulation proposed here to multi-locus and/or environment factor case, including 
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gene-gene interaction and gene-environment interaction analyses while POE is integrated. 
Conceptually, this generalization should fairly straightforward by applying the Kronecker product 
rule as in [21], if we assume linkage equilibrium between loci and no association between a genetic 
locus and an environment factor. However, it would probably be challenging to deal with and 
properly interpret a large number of interaction terms. The extension, nevertheless, would be 
attractive as imprinting effects of one locus may indeed have complex interaction with main effects 
of other loci. We are currently working along this direction. 
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CONCLUSIONS 
 
      To investigate the properties and application of the NOIA framework on association studies, we 
implemented it in three directions. First, we generalized the NOIA coding technique to the full model 
and reduced models (including additive, dominant and recessive) allowing for GxG interaction 
testing. Through extensive simulation studies, we demonstrated greater statistical power of the NOIA 
model comparing with the usual approach.  The newly developed methods were applied to 
melanoma datasets. Through real data analyses, we confirmed that NOIA model had obviously 
greater power on detecting the main genetic effects and interaction effects compared to the usual 
approach. We also validated several previously identified causal variants of melanoma and found 
some novel gene-gene interactions. Further experiments need to be carried out to verify these 
interactions. 
      To explore the extension of the NOIA framework for detecting GxE interactions, we developed a 
novel statistical approach that allows us to model effects from a genetic factor and binary 
environmental exposure that are jointly influencing disease risk. Through extensive simulation 
studies, we demonstrated greater statistical power of the NOIA GxE model on detecting the main 
effects and interaction effects comparing with the usual approach. To evaluate the performance of 
the newly developed method, we applied it on lung cancer datasets. Our results of identifying the 
causal variants were consistent with previous studies. Moreover, we also found some novel gene-
environment interactions for lung cancer risk. 
      We also developed a statistical approach for modeling genetic effects due to imprinting effects in 
the orthogonalized framework. The POEs are usually ignored in traditional approaches (for example, 
GWAS), which were designed to only detect the overall genetic effect, resulting in weaker tests and 
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lower estimate of heritability of human complex diseases and traits. We believe that incorporations 
of POEs detecting into association studies could solve this problem to some extent, and estimating 
the effects and testing for imprinting is important for further delineating the complex genetic 
architecture for human diseases and traits. Extensive simulation studies demonstrated the statistical 
performance of the new methodology that we have developed. We found that Stat-POE model had 
better performance on detecting the main allelic additive effect than the Func-POE model for both 
quantitative traits and qualitative traits.  We also found that Stat-POE model had better performance 
on detecting the main allelic additive effect than the Stat-Usual model for case-control traits when 
strong POE exists.  
      We believe that the new methods that we have developed will be useful in further understanding 
the impact of gene-gene interactions, gene-environment interactions and imprinting effects on human 
complex traits and diseases. Orthogonal methods are useful for improving estimation of effects 
particularly when multiple loci or environmental factors are jointly contributing to the outcome and 
when GxG/GxE interactions are investigated, especially when imprinting effects are incorporated 
into the modeling. Through our implementation, the NOIA framework could be a more unified and 
comprehensive system for detecting GxG/GxE interactions and even POE, which will provide 
invaluable insight into the efforts for finding the “missing heritability”. And the revealed interactions 
will be useful to help explain the underlying mechanism of the development of lung cancer and 
melanoma. 
Next, we will extend our newly developed orthogonal models to higher dimensional interactions 
which could be easily reached by applying the Kronecker product, for example, GxGxG or GxGxE 
interactions modeling or GxG/GxE interactions testing with consideration of imprinting effects. The 
more than two dimensional interactions have not been widely investigated; however, they may 
indeed explain some of the heritability of human complex diseases and traits. We will also explore to 
explore the application of our models to the cases when the loci are not in HWE or the parent origin 
information is missed. 
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APPENDIX 
Appendix 1: Supplementary figures and tables 
 
Figure S2.1 Density distributions of the estimates of the parameters from a simulated data analysis 
with a quantitative trait influenced by two loci and positive interaction coefficients.  
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Figure S2.2 Density distributions of the estimates of the parameters from a simulated data analysis 
with a quantitative trait influenced by two loci and negative interaction coefficients.  
 
 
 
Figure S2.3 Density distributions of the estimates of the parameters from a simulated data analysis 
with a quantitative trait influenced by two loci and no gene-gene interactions.  
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Figure S2.4 Density distributions of the estimates of the parameters from a simulated data analysis 
with a case-control trait influenced by two loci and positive g interaction coefficients.  
 
 
 
 
Figure S2.5 Density distributions of the estimates of the parameters from a simulated data analysis 
with a case-control trait influenced by two loci and negative interaction coefficients.  
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Figure S2.6 Density distributions of the estimates of the parameters from a simulated data analysis 
with a case-control trait influenced by two loci and no gene-gene interactions.  
 
 
 
Figure S2.7 Power under different critical values of the P values obtained using the Wald test for the 
quantitative simulation data influence by two loci and positive interaction coefficients. The minor 
allele frequency was 0.50. The upper panel is for the additive effects and dominant effects of locus A 
and locus B, respectively. The bottom panel is for the interaction effect between locus A and locus 
B. The simulating values of the genetic effects were Ers.  100.00, 1.50, 0.40, 1.10, 0.50, 0.80, 0.23, 0.32, 0.12. Corresponding values of the 
statistical genetic effects were Ers4  104.16, 2.46, 0.69, 2.02, 0.88, 0.8, 0.23, 0.32, 0.12.  
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Figure S2.8 Power under different critical values of the P values obtained using the Wald test for the 
quantitative simulation data influence by two loci and negative interaction coefficients. The minor 
allele frequency was 0.50. The upper panel is for the additive effects and dominant effects of locus A 
and locus B, respectively. The bottom panel is for the interaction effect between locus A and locus 
B. The simulating values of the genetic effects were Ers.  100.00, 1.50, 0.40, 1.10, 0.50, 20.80, 20.23, 2 0.32, 20.12. Corresponding values of the 
statistical genetic effects were Ers4  101.95, 0.54, 0.11, 0.18, 0.12, 20.80, 20.23, 20.32, 20.12. 
 
 
 
Figure S2.9 Power under different critical values of the P values obtained using the Wald test for the 
quantitative simulation data influence by two loci no interaction effects. The minor allele frequency 
was 0.50. The upper panel is for the additive effects and dominant effects of locus A and locus B, 
respectively. The bottom panel is for the interaction effect between locus A and locus B. The 
simulating values of the genetic effects were Ers.  100.00, 1.50, 0.40, 1.10, 0.50, 0.0, 0.0, 0.0, 0.0. Corresponding values of the statistical 
genetic effects were Ers4  103.05, 1.50, 0.40, 1.10, 0.50, 0.0, 0.0, 0.0, 0.0. 
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Figure S2.10 Q-Q plot for P values of genotyped SNPs obtained from NOIA statistical model on 
additive effect estimation. lambda=1.011. 
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Figure S2.11 Q-Q plot for P values of genotyped SNPs obtained from NOIA statistical model with 
dominance component detection on additive effect estimation, lambda=1.014. SNPs with genotype 
frequency of any homozygote less than 0.005 were filtered. 
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Table S2.1 Results from genome-wide association analysis of melanoma by NOIA statistical one-
locus model using logistic regression (p  1.0  10
).  
 
CH
R SNP A1 A2 
A2 
freq Coordinate OR 
2.5%
CI 
97.5% 
CI P 
Gene 
Symbol 
1 rs2089427 A G 0.45 213637204 1.24 1.11 1.39 9.96E-05 LOC643536 
1 rs6693552 A C 0.18 238280547 1.34 1.16 1.55 9.39E-05 LOC645884 
1 rs12733694 A G 0.18 238284757 1.34 1.16 1.56 7.69E-05 FMN2 
1 rs11204754 A G 0.5 149227878 0.8 0.72 0.89 6.43E-05 ANXA9 
1 rs12753507 A G 0.43 213446975 1.24 1.11 1.39 9.81E-05 KCNK2 
1 rs1722784 A G 0.5 149228493 1.26 1.13 1.4 3.59E-05 ANXA9 
1 rs11506 A G 0.07 163898130 0.67 0.55 0.82 8.57E-05 ALDH9A1 
1 rs10926064 A G 0.64 238240621 1.27 1.14 1.42 2.67E-05 LOC645884 
2 rs2060167 A G 0.75 166397588 1.29 1.14 1.46 7.46E-05 TTC21B 
2 rs12471713 C G 0.88 65957786 1.48 1.26 1.75 2.98E-06 FLJ16124 
2 rs3791511 A G 0.88 239745477 0.7 0.58 0.83 7.71E-05 HDAC4 
2 rs2083244 A G 0.39 119377691 0.79 0.71 0.88 4.14E-05 MARCO 
3 rs4643673 A G 0.36 148129994 0.79 0.7 0.88 3.52E-05 PLSCR5 
3 rs3912449 A G 0.14 7658162 0.73 0.63 0.85 5.98E-05 GRM7 
3 rs9790140 A C 0.92 96158387 1.49 1.23 1.82 5.97E-05 WDR82P1 
3 rs6549877 A G 0.87 28720143 1.37 1.17 1.61 9.04E-05 C3orf53 
3 rs1872396 A G 0.86 7655452 1.38 1.18 1.61 4.46E-05 GRM7 
4 rs17035512 C G 0.88 106509509 1.4 1.19 1.65 4.50E-05 PPA2 
4 rs6811159 A G 0.12 106542507 0.72 0.61 0.84 6.12E-05 PPA2 
4 rs17035584 A G 0.88 106574235 1.39 1.18 1.64 7.01E-05 PPA2 
4 rs6823995 A G 0.13 106483130 0.72 0.61 0.85 6.51E-05 PPA2 
4 rs17035553 A G 0.84 106540872 1.35 1.17 1.56 5.22E-05 PPA2 
4 rs3898404 A G 0.16 106575844 0.75 0.64 0.86 8.05E-05 PPA2 
4 rs6812270 A T 0.12 106285899 0.72 0.62 0.85 9.73E-05 KIAA1546 
5 rs10940474 A G 0.34 54916458 1.3 1.16 1.47 1.49E-05 FLJ90709 
6 rs4431416 A G 0.43 68146608 1.24 1.12 1.39 9.43E-05 LOC728052 
6 rs7769019 A G 0.04 33706620 0.57 0.43 0.74 4.39E-05 ITPR3 
6 rs2495971 A C 0.16 34037043 1.38 1.18 1.61 5.47E-05 GRM4 
6 rs3087617 A T 0.08 31664635 1.54 1.24 1.91 8.64E-05 LST1 
6 rs9454109 A G 0.72 68004709 0.75 0.67 0.85 5.18E-06 RCADH5 
7 rs10245068 A C 0.89 37331759 0.68 0.56 0.82 4.53E-05 ELMO1 
8 rs2248448 A G 0.5 4528471 0.81 0.72 0.9 9.68E-05 CSMD1 
8 rs4909616 A G 0.31 135569749 0.78 0.7 0.88 4.53E-05 ZFAT1 
8 rs10094500 A C 0.51 4558681 1.28 1.15 1.43 8.41E-06 CSMD1 
8 rs2724961 A G 0.53 4547635 0.79 0.7 0.88 1.52E-05 CSMD1 
8 rs2617014 A G 0.55 4537866 0.78 0.7 0.87 6.99E-06 CSMD1 
9 rs7023954 A G 0.61 21806758 1.28 1.15 1.43 1.22E-05 MTAP 
9 rs11792508 A C 0.92 243594 1.52 1.25 1.84 2.78E-05 DOCK8 
9 SNP9-21803495 A G 0.52 21803495 0.78 0.7 0.88 1.48E-05 MTAP 
9 SNP9-21803518 A G 0.51 21803518 0.8 0.72 0.89 5.37E-05 MTAP 
9 rs1987458 A G 0.44 21694873 0.8 0.72 0.89 6.46E-05 LOC402359 
9 SNP9-21803241 A G 0.49 21803241 1.25 1.12 1.4 5.78E-05 MTAP 
9 SNP9-21816516 A G 0.38 21816516 0.78 0.7 0.87 1.29E-05 MTAP 
  
89 
 
9 SNP9-21816940 A C 0.62 21816940 1.28 1.15 1.43 1.29E-05 MTAP 
9 SNP9-21808674 A G 0.41 21808674 0.79 0.7 0.88 1.68E-05 MTAP 
9 SNP9-21786791 A G 0.63 21786791 1.29 1.15 1.44 9.87E-06 MTAP 
9 SNP9-21817406 A G 0.38 21817406 0.78 0.7 0.88 1.64E-05 MTAP 
9 rs10811615 A G 0.55 21772164 1.25 1.12 1.39 8.34E-05 LOC402359 
9 SNP9-21761241 A G 0.39 21761241 0.79 0.7 0.88 2.43E-05 MTAP 
9 SNP9-21818242 A G 0.52 21818242 0.79 0.71 0.88 2.23E-05 MTAP 
9 SNP9-21806637 A G 0.41 21806637 0.78 0.7 0.87 1.03E-05 MTAP 
9 SNP9-21796564 A G 0.62 21796564 1.28 1.14 1.43 1.42E-05 MTAP 
9 rs1561650 A G 0.39 21742358 0.8 0.71 0.89 6.87E-05 LOC402359 
9 SNP9-21778782 A G 0.61 21778782 1.27 1.14 1.42 1.78E-05 MTAP 
9 SNP9-21775139 A T 0.39 21775139 0.78 0.7 0.88 1.80E-05 MTAP 
9 SNP9-21803718 A G 0.47 21803718 0.78 0.7 0.87 8.04E-06 MTAP 
9 SNP9-21775018 A G 0.61 21775018 1.27 1.14 1.42 2.45E-05 MTAP 
9 SNP9-21799077 A T 0.62 21799077 1.27 1.14 1.42 2.26E-05 MTAP 
9 SNP9-21777262 A G 0.61 21777262 1.28 1.14 1.42 1.72E-05 MTAP 
9 SNP9-21818110 A C 0.38 21818110 0.78 0.7 0.87 1.11E-05 MTAP 
9 rs10965144 A G 0.62 21798913 1.26 1.13 1.41 3.74E-05 MTAP 
9 SNP9-21774758 A T 0.61 21774758 1.27 1.14 1.42 2.07E-05 MTAP 
9 SNP9-21778481 A G 0.39 21778481 0.79 0.7 0.88 2.03E-05 MTAP 
9 rs3928894 A G 0.49 21808310 1.25 1.12 1.39 7.84E-05 MTAP 
9 SNP9-21806646 A G 0.51 21806646 0.8 0.72 0.89 6.39E-05 MTAP 
9 rs10965133 A G 0.61 21778656 1.27 1.14 1.42 2.06E-05 LOC402359 
9 SNP9-21760951 A G 0.39 21760951 0.79 0.71 0.88 3.26E-05 MTAP 
9 rs1335503 A G 0.39 21727822 0.8 0.72 0.9 8.94E-05 LOC402359 
9 SNP9-21783177 A C 0.48 21783177 0.79 0.71 0.89 3.40E-05 MTAP 
9 SNP9-21768660 A G 0.55 21768660 1.25 1.12 1.39 7.80E-05 MTAP 
9 SNP9-21764467 A G 0.48 21764467 0.8 0.72 0.9 8.78E-05 MTAP 
9 rs1335500 A G 0.49 21701675 1.32 1.18 1.47 6.24E-07 LOC402359 
9 SNP9-21751440 C G 0.52 21751440 1.24 1.11 1.39 9.04E-05 MTAP 
9 SNP9-21761756 A G 0.48 21761756 0.8 0.72 0.89 6.86E-05 MTAP 
9 SNP9-21762267 A G 0.48 21762267 0.8 0.72 0.9 8.11E-05 MTAP 
9 rs12380505 A G 0.5 21685893 0.76 0.68 0.85 6.02E-07 LOC402359 
9 SNP9-21780669 C G 0.52 21780669 1.26 1.13 1.4 4.27E-05 MTAP 
9 SNP9-21794693 A G 0.48 21794693 0.79 0.71 0.89 3.14E-05 MTAP 
9 rs10811582 A G 0.4 21682017 1.29 1.16 1.45 5.80E-06 LOC402359 
9 SNP9-21775304 C G 0.52 21775304 1.24 1.11 1.38 9.91E-05 MTAP 
9 SNP9-21765061 A G 0.48 21765061 0.8 0.72 0.9 8.23E-05 MTAP 
9 SNP9-21780142 C G 0.52 21780142 1.25 1.12 1.39 6.32E-05 MTAP 
9 rs896655 A G 0.39 21696571 0.8 0.72 0.89 6.69E-05 LOC402359 
9 SNP9-21763167 C G 0.48 21763167 0.8 0.72 0.89 4.74E-05 MTAP 
9 rs2383202 A G 0.49 21700215 1.32 1.19 1.47 5.24E-07 LOC402359 
9 SNP9-21780067 A G 0.48 21780067 0.8 0.72 0.89 6.90E-05 MTAP 
9 SNP9-21778523 A G 0.48 21778523 0.8 0.72 0.9 8.15E-05 MTAP 
9 SNP9-21755601 A G 0.52 21755601 1.24 1.11 1.39 9.27E-05 MTAP 
9 SNP9-21765957 A G 0.52 21765957 1.25 1.12 1.39 7.01E-05 MTAP 
9 SNP9-21759412 A G 0.52 21759412 1.24 1.11 1.39 9.77E-05 MTAP 
9 SNP9-21792469 A G 0.47 21792469 0.8 0.71 0.89 3.49E-05 MTAP 
9 rs7866787 A G 0.48 21750639 0.8 0.72 0.9 7.94E-05 LOC402359 
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9 SNP9-21778081 A C 0.48 21778081 0.8 0.72 0.89 7.24E-05 MTAP 
9 rs7848524 A G 0.5 21691432 0.76 0.68 0.84 4.28E-07 LOC402359 
9 rs7023329 A G 0.47 21806528 0.79 0.71 0.88 1.27E-05 MTAP 
9 rs6475552 A G 0.5 21691674 1.32 1.19 1.48 3.71E-07 LOC402359 
9 rs1345026 A G 0.58 21735756 0.79 0.7 0.88 2.43E-05 LOC402359 
9 rs1452658 A G 0.5 21690795 1.32 1.18 1.47 7.22E-07 LOC402359 
9 SNP9-21789598 A G 0.49 21789598 0.75 0.68 0.84 4.15E-07 MTAP 
10 rs2797272 A G 0.24 9125309 0.77 0.68 0.88 5.74E-05 LOC389936 
10 rs11001702 A G 0.09 53773431 0.67 0.56 0.8 1.25E-05 DKK1 
11 rs644817 A C 0.93 69749575 0.62 0.48 0.78 7.88E-05 FADD 
12 rs12826471 A G 0.84 3455203 0.71 0.61 0.83 1.53E-05 PRMT8 
13 rs2202561 A G 0.61 70442966 1.26 1.13 1.41 5.69E-05 LOC647277 
13 rs7995083 A G 0.13 23043162 1.41 1.2 1.67 4.96E-05 TNFRSF19 
13 rs17691655 A G 0.76 70445908 1.34 1.18 1.52 5.23E-06 LOC647277 
14 rs7150290 A G 0.14 52220859 1.4 1.19 1.64 4.10E-05 ERO1L 
15 rs8030574 A C 0.23 71415267 0.77 0.68 0.88 9.47E-05 HCN4 
15 rs1129038 A G 0.22 26030454 0.7 0.61 0.79 3.73E-08 HERC2 
15 rs12913832 A G 0.78 26039213 1.43 1.25 1.62 6.15E-08 HERC2 
16 rs11648898 A G 0.18 88573487 1.57 1.35 1.84 1.46E-08 AFG3L1 
16 rs4238833 A C 0.4 88578190 1.34 1.2 1.5 4.56E-07 AFG3L1 
16 rs10852628 A G 0.31 88607428 1.4 1.24 1.58 6.94E-08 DBNDD1 
16 rs258322 A G 0.88 88283404 0.63 0.53 0.76 1.13E-06 CDK10 
16 rs164741 A G 0.65 88219799 0.76 0.67 0.85 2.44E-06 DPEP1 
16 rs4785751 A G 0.53 88556918 1.43 1.29 1.6 1.13E-10 DEF8 
16 rs17827507 A G 0.27 83202987 0.77 0.68 0.86 1.43E-05 COTL1 
16 rs4785752 A G 0.53 88562642 0.73 0.66 0.82 4.14E-08 DEF8 
16 rs352935 A G 0.52 88176081 1.25 1.12 1.39 8.26E-05 CPNE7 
16 rs4785759 A C 0.53 88578381 0.73 0.66 0.82 4.26E-08 AFG3L1 
16 rs8051733 A G 0.36 88551707 1.42 1.27 1.59 2.66E-09 DEF8 
16 rs4408545 A G 0.54 88571529 1.43 1.28 1.59 3.81E-10 AFG3L1 
16 rs4785763 A C 0.63 88594437 0.75 0.67 0.84 1.23E-06 AFG3L1 
16 rs11076650 A G 0.46 88595442 1.4 1.26 1.56 1.65E-09 DBNDD1 
16 rs7195043 A G 0.5 88548362 0.72 0.64 0.8 5.73E-09 DEF8 
16 rs9939542 A C 0.3 88580549 1.33 1.18 1.51 3.15E-06 AFG3L1 
17 rs3744578 A G 0.21 11589057 1.32 1.15 1.52 8.33E-05 DNAH9 
17 rs9904264 A G 0.21 11587008 1.34 1.17 1.54 3.96E-05 DNAH9 
17 rs16957962 A G 0.33 9000751 1.29 1.14 1.45 2.85E-05 NTN1 
19 rs868878 A G 0.88 7737047 0.69 0.57 0.82 4.60E-05 CLEC4M 
19 rs2285963 A G 0.88 5542735 1.42 1.21 1.68 2.57E-05 SAFB2 
19 rs934433 A G 0.6 36000617 0.79 0.7 0.88 1.86E-05 ZNF536 
19 rs934432 A C 0.4 36000424 1.27 1.14 1.42 1.66E-05 ZNF536 
19 rs6510181 A C 0.39 35984559 1.25 1.12 1.4 6.43E-05 ZNF536 
19 rs1549951 A G 0.61 35984184 0.8 0.71 0.89 6.85E-05 ZNF536 
19 rs3745542 A G 0.3 56279455 1.32 1.17 1.49 7.87E-06 KLK14 
20 rs2284271 A G 0.91 43038835 1.47 1.21 1.78 8.12E-05 STK4 
20 rs17730901 A C 0.88 16198822 1.39 1.18 1.63 7.78E-05 C20orf23 
20 rs4814466 A G 0.88 16201819 1.39 1.18 1.64 6.24E-05 C20orf23 
20 SNP20-31969319 C G 0.89 31969319 0.68 0.57 0.82 7.25E-05 CHMP4B 
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Figure S3.1 Density distributions of the estimates of the parameters from a simulated data analysis, 
illustrated in Figure 3.1. The pre-specified minor allele frequency and exposure frequency was 0.30 
and 0.22, respectively. The simulating residual variance was 144.0. The values of the six 
parameters of the genetic effects were Ers.   100.0,  3.0,  1.0,  2.0,  1.5,  1.0. The corresponding 
statistical genetic effects were s²³  101.75,  4.18,  1.22,  2.71,  2.2,  1.0. The solid arrows 
denote the true simulated values of the parameters for the NOIA statistical model and the dashed 
arrows denote those for the usual functional model. 
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Figure S3.2 Density distributions of the estimates of the parameters from a simulated data 
analysis, illustrated in Figure 3.2. The pre-specified minor allele frequency and exposure 
frequency was 0.30 and 0.22, respectively. The simulating residual variance was 144.0. The 
values of the six parameters of the genetic effects were Ers.   100.0,  3.0,  1.0,  0.0,  0.0,  0.0. The corresponding statistical genetic effects were s²³  101.16,  3.70,1.00,0.00,0.00,0.00. The solid arrows denote the true simulated values 
of the parameters for the NOIA statistical model and the dashed arrows denote those for the 
usual functional model. 
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Figure S3.3 Density distributions of the estimates of the parameters from a simulated data 
analysis, illustrated in Figure 3.3. The pre-specified minor allele frequency and exposure 
frequency was 0.25 and 0.22, respectively. The values of the six parameters of the genetic 
effects were Ers.  22.0,  0.3,  0.1,  0.2,  0.1,  0.04. The corresponding statistical genetic 
effects were s²³  21.75,  0.38,  0.11,  0.27,  0.12,  0.04. The solid arrows denote the true 
simulated values of the parameters for the NOIA statistical model and the dashed arrows 
denote those for the usual functional model. 
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Figure S3.4 Density distributions of the estimates of the parameters from a simulated data analysis, 
illustrated in Figure 3.4. The pre-specified minor allele frequency and exposure frequency was 0.25 
and 0.22, respectively. The values of the six parameters of the genetic effects were s´³ 22.0,  0.4,  0.2,  0.0,  0.0,  0.0. The corresponding statistical genetic effects were s²³ 21.73,  0.5,  0.2,  0.0,  0.0,  0.0. The solid arrows denote the true simulated values of the parameters 
for the NOIA statistical model and the dashed arrows denote those for the usual functional model. 
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Figure S4.1 Power under different critical values of the P values obtained using the Wald test for the 
quantitative simulation data influence by a genetic factor with strong POE (scenario 1). The minor 
allele frequency was 0.03. Power for detecting (a) the main allelic additive effect, (b) the POE and 
(c) the dominant effect. 
 
 
 
Figure S4.2 Power under different critical values of the P values obtained using the Wald test for the 
quantitative simulation data influence by a genetic factor with strong POE (scenario 1). The minor 
allele frequency was 0.48. Power for detecting (a) the main allelic additive effect, (b) the POE and 
(c) the dominant effect. 
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Figure S4.3 Power under different critical values of the P values obtained using the Wald test for the 
case-control simulation data influence by a genetic factor with POE. The minor allele frequency was 
0.03. Power for detecting (a) the main allelic additive effect, (b) the POE and (c) the dominant effect. 
 
 
 
 
Figure S4.4 Power under different critical values of the P values obtained using the Wald test for the 
case-control simulation data influence by a genetic factor with POE. The minor allele frequency was 
0.48. Power for detecting (a) the main allelic additive effect, (b) the POE and (c) the dominant effect. 
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Table S3.1 Distributions of selected demographic variables of the ILCCO dataset 
 
 
 
 
 
 
 
Table S3.2 Summary of the SNPs that we used in ILCCO dataset a 
 
Chromosomal locus 
and variant 
Risk 
Allele MAF Case Control Non.smoker.freq SNPs 
rs2736100_chr5p15 C 0.51 6684 9558 0.24 0=AA 1=AC 2=CC 
rs402710_chr5p15 G 0.65 6682 8054 0.22 0=GG 1=GA 2=AA 
rs2256543_chr6p21 A 0.44 6781 9621 0.24 0=GG 1=GA 2=AA 
rs4324798_chr6q21 A 0.09 7283 10163 0.23 0=GG 1=GA 2=AA 
rs16969968_chr15q25 A 0.35 7186 10070 0.23 0=GG 1=GA 2=AA 
rs8034191_chr15q25 G 0.35 5070 8316 0.19 0=AA 1=AG 2=GG 
  a Non.smoker.freq=the frequency of non-smokers;  
 
 
 
Variables Case patients, No. (%) Control subjects, No. (%) 
Sex 
  
  Male 4334(59) 6054(58) 
   Female 3058(41) 4390(42) 
Age(year) 
  
   <50 1043(14) 2172(21) 
   50-59 1823(25) 2704(26) 
   60-69 2594(35) 3430(33) 
   70-79 1682(23) 1969(19) 
   >=80 206(3) 141(1) 
Smoking status 
 
   never 735(10) 3344(32) 
   former smokers 3033(41) 3873(37) 
   current smokers 3524(48) 2772(27) 
   ever smokers 100(1) 455(4) 
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Appendix 2: One-Locus and Two-Locus Scan by the NOIA and Usual Functional model 
 
Appendix 2.1: Gene-gene interaction: Reduced models 
      Ma et.al [22] stated the reduced one-locus models for NOIA statistical and usual models, 
including the additive, recessive, dominant models. Hereafter we are showing the corresponding 
two-locus models.  
      If the gene is additive, we have the following two-locus statistical model 
"
##
##
#$
GGGGGGGGG&
''
''
'(  51 2N7m1 1 2 N7m1 2 2 N7m; n 5
1 2N7k1 1 2 N7k1 2 2 N7k; 5
μαkαmαα; 
"
###
###
#$
1 2N7k1 1 2 N7k1 2 2 N7k
2N7m N7kN7m2N7m 2C1 2 N7kDN7m2N7m 2C2 2 N7kDN7m1 2N7k1 1 2 N7k1 2 2 N7k
1 2 N7m 2N7kC1 2 N7mD1 2 N7m C1 2 N7kDC1 2 N7mD1 2 N7m C2 2 N7kDC1 2 N7mD1 2N7k1 1 2 N7k1 2 2 N7k
2 2 N7m 2N7kC2 2 N7mD2 2 N7m C1 2 N7kDC2 2 N7mD2 2 N7m C2 2 N7kDC2 2 N7mD&
'''
'''
'(
5 μαkαmαα;, 
and functional model: 
Gkm  )1 01 11 2* n )
1 01 11 2* 5
Rakamaa; 
"
###
##$
1 01 11 2
0 00 00 01 01 11 2
1 01 11 21 01 11 2
2 02 22 4&
'''
''( 5 Rakamaa;. 
They are related as  
5 μαkαmαα;  1
1 N7k0 1 N7m 2N7kN7m0 N7m0 00 0 1 N7k0 1 3 5
Rakamaa;. 
      If the gene is recessive, we have the following two-locus statistical model 
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They are related as  
5 μαkαmαα;  5
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0 1 q 2pq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0 00 0 1 2p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Rakamaa;. 
      If the gene is dominant, we have the following two-locus statistical model 
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They are related as  
5 μαkαmαα;  1
1 p 2 10 1 q 2 1 2C1 2 pDC1 2 qD0 q 2 10 00 0 1 p 2 10 1 3 5
Rakamaa;. 
 
Appendix 2.2: Test Statistics for Full and Reduced One-Locus Models 
The wald test statistic is z  PQRSJPQK, where  
βZ  CXEXDXEy covJβZK  σCXEXD  gseJβZKh 
The n rows of matrix  Z represent the corresponding genotype for individual i. And X  Z  S. 
Z 
"
#$
1% 0% 0%0% 1% 0%0% 0% 1% &
'(, and  ZEZ  n )p 0 00 p 00 0 p* 
XEX  CZSDEZS  SEZEZS 
We recall that, N7  p  2p, V  p  4p 2 N7   4pp  pp  pp. 
For NOIA statistical model with no dominance component modeled,  
S  )1 2N71 1 2 N71 2 2 N7* 
XEX  SEZEZS  g 1 1 12N7 1 2 N7 2 2 N7h  n )p 0 00 p 00 0 p*  )
1 2N71 1 2 N71 2 2 N7*  n g1 00 Vh det CXEXD  nV 
CXEXD  1nV gV 00 1h 
Then z  PQRSJPQK  JTUTKVWTUXe_`CTUTDVW  Wµ¶gI  hg   F7 F7 F7h·UXa¸`µ¶c√I  d  √_`I c√V √V √V2N7 1 2 N7 2 2 N7d  ZEy 
For NOIA statistical model with dominance component, 
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S4 
"
##$
1 2N7 2 2ppV1 1 2 N7 4ppV1 2 2 N7 2 2p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V &
''( 
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p/V 4p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/V 22p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/V*  )
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 0 00 p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"
##$
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V &
''(  n 1
1 0 00 V 00 0 4p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pV 3 
det CXEXD  4nppp 
CXEXD  14nppp 1
4ppp 0 00 4pppV 00 0 V3 
Then we got the test statistic for the NOIA one-locus full mode as follows: 
z  PQRSJPQK  JTUTKVWTUXe_`CTUTDVW  √_`I  "$
√V √V √V2N7 1 2 N7 2 2 N72abW`b``bWW 2abWWb``bW` 2abWWbW`b`` &( Z
Ey. 
For usual functional model with no dominance component modeled,  
S  )1 01 11 2* 
XEX  SEZEZS  g1 1 10 1 2h  n )p 0 00 p 00 0 p*  )
1 01 11 2*  n c1 N7N7 N7  2pd det CXEXD  nV 
CXEXD  1nV cN7  2p 2N72N7 1 d 
z  βZseJβZK  CXEXDXEyeσCXEXD  1√nσV  5aN7  2p
2peN7  2p 2peN7  2p2N7 1 2 N7 2 2 N7 ;  ZEy 
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It results in the same test statistic as the NOIA model for the additive effect estimating. 
For usual functional model with dominance component modeled,  
XEX  S.EZEZS.  n )1 1 10 1 20 1 0*  )
p 0 00 p 00 0 p*  )
1 0 01 1 11 2 0*  n 5
1 N7 pN7 p  4p pp p p; detCXEXD  4nppp 
CXEXD  14nppp 5
4pp 22pp 22pp22pp pC1 2 pD 2pC1 2 N7D22pp 2pC1 2 N7D V ; 
z  βZseJβZK  CXEXDXEyeσCXEXD  1√nσV
"
###
###
$ ¹ Vp 0 0
2¹ pVpC1 2 pD 0 ¹ pVpC1 2 pD
2¹ppp 2¹ppp 2¹ppp &
'''
'''
(
ZEy 
From the second row of the matrix, we observe that the test statistic for the additive effect is different 
with those of the previous three models. And the test statistic z is smaller. 
 
Appendix 3 POE models 
 
Appendix 3.1: POE models before transformation 
 a and a (or α, α) denote the POE, from maternal and paternal origin, respectively. We extended 
the usual functional (Func-Usual) model (3) to the POE functional (Func-POE) model by 
incorporating a POE parameter into the model, and similar steps were carried out for the usual 
statistical model (Stat-Usual) (5) and resulted in a POE statistical model (Stat-POE).  
Model 1: POE functional (Func-POE) model: 
      Under the usual coding approach, the genotypic value G could be expressed as 
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G  º G  RG  R  a  dG  R  a  dG  R  a  a
¡
. (A1) 
      That is  
1GGGG3  S.E.  5
1 01 0 0 01 11 11 1 0 11 0; 5
Raad ;. (A2) 
       The inverse is  
E.W  S.W G, 
5 Raad ;  "
#$
1 02  2  0 0 2  2  
2   2 &
'( 1
GGGG3. (A3) 
Simply, we could express genotypic value G on the number of the paternal or maternal reference 
allele, as follows: 
G  R  Na  Na  εd. (A4) 
 Model 2: POE statistical (Stat-POE) model: 
      From multiple linear regression, βZ  JXXKXy.  βZ consists of three of the four regression 
parameters, μ, α and α. X is a n  3 vector of N and N information and 
X 
"
##$
111
001
0101…1
1…0
1…0&
''(. (A5) 
y is the observed trait phenotype and y  Z  G when those observations perfectly fit the genotypic 
values in ideal situations. Therefore, we could get the expression of the three parameter in βZ, as 
βZ  JXXKXZG . Additionally, the dominance effect δ  W`f`W 2 WWf`` . After 
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combining the coding of the additive effects and dominant effects, adjusting the coding for the 
intercept term μ,  finally we got  
E4W  5 μααδ ;  S4WG  "#
$ p ppE pE p ppE   pE   pEE  pEE   2   p
EE pEE 2  &'
( 1GGGG3. (A6) 
S4W can also be expressed as  
"
##$
p pbWWb`WF7`£ bW`b``CF7`D£
p pbWWb`WF7 `£     bW`b``CF7`D£bWWbW`F7 W£ bWWbW`F7 W£   2  
b`Wb``CF7WD£ b`Wb``CF7WD£ 2  &
''(. (A7) 
The inverse is  
G  S4WE4W 
It could be also expressed as 
G  μ  CN 2 N7Dα  CN 2 N7Dα  εδ, (A8) 
which is equal to 
1GGGG3  S4WE4W  "#
$ 1 2N71 2N7 2N7  ε1 2 N7  ε    1 1 2 N7    1 1 2 N7 2N7 ε1 2 N7 ε &'
( 5 μααδ ;. (A9) 
     This relation between the functional model and the statistical model parameters is  
5 μααδ ;  1
1 N70 1 N7 p  p0 pE  pE0 00 0 1 pEE  pEE0 1 3 5
Raad ;. (A10) 
      Then, we transformed these two models to two equivalent models (18) and (21) by re-
parameterization using r  a  a, r  a 2 a for the functional model and  γ  α  α, γ  α 2 α for the statistical model. These two frameworks are equivalent to some extent, 
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whereas the transformed one is more straightforward than this original framework for nominating the 
overall genetic effect and POE separately. 
Appendix 3.2: Orthogonality of the Stat-POE model before transformation 
      In the Stat-POE model, from Equation A7, we could decompose the variance of the phenotypic 
value as  
V  VarCN 2 N7Dα  VarCN 2 N7Dα  VarCεδD  2CovCN 2 N7Dα, CN 2 N7Dα, (B1) 
as 
CovCN 2 N7Dα, εδ  αδCovCN, εD  0, (B2) 
and similarly,  
CovCN 2 N7Dα, εδ  αδCovCN, εD  0. (B3) 
Moreover, VarCεδD  δvarCεD  4ppppδ/D. Therefore, we could express the additive 
and dominant variance components as 
V»  αVarCND  αVarCND  2ααCovCN, ND, (B4) Vª  4ppppδ/D. (B5) 
      To show that the additive variance, V», could be decomposed to be two parts which are only 
dependent on two additive effects (γand γ), respectively, CovCN, ND  0 needs to be satisfied. 
And as we know CovCN, ND  ECNND 2 ECNDECND  p 2 N7N7  pp 2 pp which 
indeed equals to 0 if the locus is in HWE. In this way, 
V»W  αVarCND  αV, (B6) V»`  αVarCND  αV. (B7) 
      The two additive variance components V»W and V»`  is related only to the additive effects α and α, respectively, with one due to maternal alleles and the other due to paternal alleles. The dominant 
variance component Vª is only related with the dominant effect δ, This property of the variance 
component to be divided into two independent additive components and one dominant component 
supports the notion that the POE statistical model before transformation is orthogonal.  
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Appendix 3.3: Orthogonality of the Stat-POE model after transformation 
      Except the variance component decomposition approach, the orthogonality of the Stat-POE 
models could also be checked by showing X  X is a diagonal matrix in which X is the n  4 design 
matrix for the sample. As described in the original NOIA paper[21], 
X  X  n S  D  S (C1) 
needs to be satisfied, where 
D  1p 00 p 0 00 00 00 0 p 00 p3. (C2) 
Given that S  JsAK shown in equation (5) with s  1, from (C1) and (C2) we derive the criteria 
for orthogonality when POE incorporated as 
ps  pspsNps
  0, (C3) psN  psNpsNNps
N  0, (C4) ps
  ps
psN
ps

  0, (C5) pssN  pssNpsNsNNps
s
N  0, (C6) pss
  pss
psNsN
ps
s

  0, (C7) psNs
  psNs
psNNsN
ps
Ns

  0. (C8) 
Except equation (C6), all of these criteria are satisfied by S in equation (5). And for equation (C6), 
pssN  pssNpsNsNNps
s
N  Cb`WbW`DCb``bWWD
  0 when p  p or p  p holds true. 
Appendix 3.4: Orthogonality of the Func-POE models 
We also checked the variance decomposition of the Func-POE models before and after 
transformation.  
    For the Func-POE model before transformation, as from Equation (A4),  
V  aVarCND  aVarCND  VarCεdD  aaCovCN, ND  adCovCN, εD  adCovCN, εD, (D1) 
where CovCN, ND=0 under HWE which I already showed previously in Appendix 3.2, and 
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CovCN, εD  p 2 Cp  pDCp  pD CovCN, εD  p 2 Cp  pDCp  pD. 
Neither of them was equal to 0 even when the locus was under HWE.  
      For the Func-POE model after transformation, as from Equation (10),  
V  °W`
 VarCN  ND  °``
 VarCN 2 ND  VarCεdD  °W± CovCN  N, εD  °`± CovCN 2 N, εD, (D2) 
where CovCN  N, εD  Cp  pDCp 2 pD is not equal to 0, and CovCN 2 N, εD Cp  pDCp 2 pD  0 if it is under HWE. 
   V  °W`
 VarCN  ND  °``
 VarCN 2 ND  VarCεdD  °W± CovCN  N, εD. (D3) 
 Therefore, even if the HWE assumption holds, the variance of the Func-POE models could not be 
expressed as the completely decomposed form as could the Stat-POE models, which confirms that 
the Func-POE models were not orthogonal. 
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